Academics
Academics
School of Medicine
Vision:
Newgiza University School of Medicine aspires to attain a leading position among medical schools in the region and to become a distinguished center for advanced scientific research, committed to graduating physicians who can serve as effective agents of change on the national, regional, and international levels ,with an active commitment to impactful community service driven by dedication and passion towards enhancing global healthcare.
Mission:
The SOM-NGU is committed to providing outstanding medical education capable of graduating competent physicians, dedicated lifelong learners, and innovative researchers, all prepared to assume leadership roles and provide exemplary, patient-centered care. Furthermore, the School fosters scientific research ,staying attuned to global developments, and affirms its societal responsibility to engage in meaningful community service.
SOM- NGU Governing Values:
The success of New Giza University’s strategic plan relies upon a set of governing values that guide the behavior of all school students, faculty members, supporting staff, employees, and the administration. The school adopts the governing values of the university in addition to:
- Objectivity
- Equality
- Transparency
- Diligence and dedication
- Teamwork
Prof. Deborah Gill, Medical School Director, UCL, Talking About NGU Collaboration With UCL
Meet the Dean
Dr. Lamiaa Mohsen,
Dean of the School of Medicine
National and international expert who worked with various governmental and international agencies in the field of health care, education, maternal and child welfare and human resource development.
In September 2016, Lamiaa was appointed as the Founding Dean for Faculty of Medicine Newgiza University which was the first School of Medicine in Egypt to implement the modular integrated curriculum and assessment.
Lamiaa is a member of the RUMP (Reform of Undergraduate Medical Program) committee shared among experts in the preparatory steps for the implementation of the new undergraduate medical curriculum that started in September 2019 in all Egyptian Medical schools.
Lamiaa is a member of the Pediatric Medical Council in the Arab Board since 2014. In this position she is responsible for the preparation, participating and evaluating OF postgraduate training and Assessment in all Arab Countries as well as accreditation of hospitals as training sites.
As a Professor of Pediatrics and Neonatology in Cairo University, Lamiaa was involved in undergraduate teaching and research with twelve international publications in the last five years. Lamiaa was appointed as Director for the Center for Social and Preventive Medicine, Cairo University, a body that links medical higher education to the health needs of the community.
Lamiaa worked with USAID and European Union projects in Indonesia, Jordan, Yemen, and Syria in the fields of Health and child protection. Her leadership skills were solidified through attending The International Health Leadership Program in Cambridge and team-leading The National Egyptian Perinatal Program.
She was appointed 2010-2012 as Secretary-General for the National Council for Childhood and Motherhood, the highest authority in Egypt responsible for protection, promotion and monitoring implementation of Child and adolescent rights in Egypt.
SOM Goals and Objectives
Goals
- First Goal: Preparing a competent doctor who possesses the competencies that enable him to compete in the local, regional and international labor market.
- Second Goal: Developing the scientific research system to achieve excellence and innovation and developing postgraduate programs
- Third Goal: Enhancing institutional capacities and sustainable development of human resources in alignment with technological development, to expand and deepen partnerships with international universities in the field of medical education for continuous development of performance.
- Fourth Goal: Continuous monitoring of of the institution’s performance to ensure the quality of the educational process and striving towards both national and international accreditation.
- Fifth Goal: Promoting community and environmental services provided by the school with a commitment to social responsibility with respect for social and cultural diversity.
Strategic Objectives:
- Strategic Objectives of the First Goal:
- Continuous development of the undergraduate program
- Enhance students’ abilities for self-development and provide them with comprehensive care.
- Strategic Objectives of the Second Goal:
- Supporting excellence and innovation in scientific research and encouraging international publishing and joint and applied research.
- Developing scientific research resources and increasing partnerships with local and international bodies.
- Raising awareness and ensuring adherence to the faculty’s code of ethics for faculty members, their assistants, administrative staff, and students.
- Launching graduate degrees in different disciplines.
- Strategic Objectives of the Third Goal:
- Enhancing the competitive position of the faculty locally and regionally.
- Continuous development of the work environment.
- Capacity building of human resources.
- Establishment and activation of the Crisis and Disasters Committee.
- Strategic Objectives of the Fourth Goal:
- Obtaining national accreditation from the National Authority for Quality Assurance and Accreditation of Education.
- Developing the self-evaluation system for the activities of the faculty.
- Strategic Objectives of the Fifth Goal:
- Assessing the needs of the surrounding community.
- Employing the human resources and resources of the faculty in serving the surrounding community, developing activities and expanding awareness services.
- Consolidating and activating the participation of community parties in the various activities of the faculty.
- Spreading the culture of volunteer work and increasing awareness of community work among students.
WHY SOM?
The SOM MBBCh program aims at producing a distinctive NGU doctor; a scientifically literate, research informed, patient minded and socially responsible professional who can serve the medical needs of individuals and communities both in Egypt and abroad.
- SOM collaborates with the esteemed institution UCL (University College London).
- It follows a modular integrated system that adheres to well-established international standards.
- Provides early clinical exposure.
- Involves 3 years of clinical undergraduate practice, followed by2 years of clinical internship.
- Adheres to international standards of teaching and assessment.
Organogram

Accreditation & Academic Collaboration
Accreditation:
Newgiza University (NGU) was established as a private university by a presidential Decree “93” in April 2010. NGU schools are acknowledged by the Ministry of Higher Education (MHE) and the Supreme Council of Universities (SCU).
The university will eventually include twelve Schools: Medicine; Pharmacy; Dentistry; Nursing and Health Science; Economics and Politics; Law; Business and Finance; Engineering; Information Technology; Arts and Design; Archaeology; and Languages and Interpretation. Currently, eight schools are functioning (Medicine, Dentistry, Pharmacy, Business and Finance, Economics and Politics, Engineering, Information Technology, and Arts and Design).
The School of Medicine was acknowledged by decree “3356” in August 2016. Every school will apply for accreditation by the National Authority for Quality Assurance and Accreditation in Education (NAQAAE) after the graduation of the first cohort.

University College London (UCL):
The School of Medicine at NGU has an academic collaboration with University College London (UCL), enhancing its academic capabilities, as well as offering world-renowned undergraduate program, providing both the school and students with ample opportunities for development on an academic and personal level.
This collaboration ensured that the highest international standards in teaching and research are met at NGU, with highly qualified faculty members providing instruction and supervision. As part of this collaboration, senior faculty, and staff from UCL worked with their NGU colleagues in strategic planning and organization of the new programs, setting up appropriate infrastructure and education governance structures, developing curricula and learning resources, faculty and senior staff recruitment, faculty development, course evaluation and education quality assurance. Where appropriate, NGU utilizes existing UCL teaching and assessment resources to deliver its programs.
Having currently ranked 9th on the QS World University Rankings 2025, and consistently placing in the top 20 of various global university rankings, UCL is widely recognized for its research capabilities and contributions to sciences and innovations. It was rated 2nd in the UK for research power in the Research Excellence Framework 2021. Moreover, UCL boasts 30 Nobel Prize winners, and was recently selected as University of the Year 2024 (The Times and Sunday Times Good University Guide 2024).
The UCL Medical School is currently ranked 6th in the world in the QS World University Rankings by Subject (2023).
Entrance Requirements
Program Summary
Program mission
The MBBCh program mission is to produce a distinctive NGU Doctor: a scientifically literate, research informed, patient-centred and socially responsible professional who can serve the health needs of individuals and communities both in Egypt and beyond.
As a student of medicine at NGU you will be joining an exciting and impressive medical school. Your degree will follow a Five-year academic program (followed by Two-years internship) that includes a stimulating Introductory Module where you will learn alongside students from the other health and life sciences programs followed by a series of ‘horizontal modules’ which focus on body systems and clinical disciplines and vertical themes which focus on important professional topics including clinical skills, professional development, social determinants of health and use of evidence, Student activities and electives.
Your Learning
You will be taught through lectures, tutorials, small-group work, laboratory classes and placements. Later years will involve attachments to teams of consultants and doctors. You will be expected to supplement learning in the university and in healthcare settings with directed self-learning.
You will be assessed by contemporary assessment methods including written exam, objective clinical teaching clinical examinations supplemented with a complete portfolio. The program integrates basic medical sciences and clinical sciences with professional skills and competencies throughout. Small group work and assigned tasks will enhance key generic skills including independent learning, critical thinking, scholarly writing and scientific method.
Program Structure
The MBBCh is five Academic years & two years internship
The MBBCh program is an integrated program. This means a deliberate blurring of the boundaries between basic science, and clinical science, between theory and practice and between disciplines. Although delivered in an integrated format, the program includes all the core basic sciences, clinical sciences, practical knowledge and skills and professional and generic skills required to address the intended learning outcomes.
The program contains 325 credit units (308 compulsory and 17 elective) . These credit units do not represent only contact hours, but the total learning effort required to achieve the learning outcomes including direct contact hours in classrooms, small groups and practical classes, workplace-based learning in clinical placements, project work, self-paced learning delivered via the Virtual Learning Environment (VLE) and self-directed learning. A credit unit is estimated to represent 25 hours of study.
Year 1 | Introductory Module and fundamentals of clinical science 1
Introductory Module.
Infection and Defence.
Behavioral Sciences.
Circulation and Breathing.
Fluids, Nutrition and Metabolism.
Year 2 | Fundamentals of Clinical Science 2, 3 & Fundamentals of Clinical Science Practice
Movement and Musculoskeletal Biology.
Endocrine Systems and Regulation.
Neuroscience and Behaviour.
Development, Genetics, and Cancer.
Foundations of Clinical Practice.
Year 3 | Integrated Clinical Care
Integrated Clinical Care 1, CVS, Respiratory& Acute Care.
Integrated Clinical Care 2, Care of Surgical Patient, Anaesthetics & General Surgery.
Integrated Clinical Care 2; Endocrinology, Haematology, Nephrology & Neurology.
Year 4 | The Life Cycle and Community Medicine
Child Health.
Women’s Health.
Family Health, Community Health, Public Health.
Year 5 | Specialist Practice and Preparation for Practice
Special Senses (Dermatology, ENT & Ophthalmology).
Oncology and Palliative Care, Care of the Elderly.
Senior Clerkship (Medicine & Surgery).
Health leadership and innovation.
Preparation for practice.
Modules:
Each year contains both horizontal modules (completed within the year) and vertical modules (running through the entire program).
Some elective modules are available to enrich the program and allow students to pursue an area of personal interest or career-related in depth.
NGU SOM internship program
The Internship Program is a structured, supervised workplace-based training two years program. It is designed to help interns to gain competence in essential clinical skills as well as other professional skills such as communication & teamwork. The program is typically made up of 2-3 month placements in a range of specialties over a period of two year. The placements provide a safe environment for the interns to apply what they learned at medical school into practice, whilst giving you the additional skills, knowledge and experience needed to practice safely as a doctor.
Internship Outline
Year 1 of the internship will be as follows,
| Specialty | Duration |
| Internal Medicine | 3 months |
| General Surgery | 3 months |
| Pediatrics | 3 months |
| Obstetrics & Gynecology | 3 months |
Year 2 of the internship, rotations will be as follows:
| Specialty | Duration |
| Anesthesia & Intensive Care | 2 months |
| Psychiatry | 2 months |
| Emergency Medicine | 2 months |
| Family Medicine (Primary Care Settings) | 2 months |
| Electives | 4 months |
Student Activities
NGU students excel at maintaining a healthy balance between rigorous academics and varied extracurricular activities. Likewise, NGU supports its students in this arduous but fruitful endeavor. While these activities are numerous, highlighted below are only a few examples:
- American Association for the Study of Liver Diseases- Egyptian Society for Liver Cancer Connect meeting
2- Egyptian Ophthalmological Society
NGU students attended the 2024 EOS conference, a comprehensive Ophthalmology conferences discussing numerous updates in this highly specialized branch of Medicine.
3- Breast Cancer Awareness in Cooperation with Baheya Foundation
4- Internal Medicine Scientific Club (IMSC)
Research





Research labs:
o Genomics and Proteomics Lab
o Cell Culture’s Lab
o Lab for Animal Studies
o Tissue Microarray and Immunohistochemistry Lab






Grants and Scientific activities office
The School of Medicine has established a Grants and scientific activities office at 2022 that has its own separate entity that is only responsible for research-related activities.

Patent:
Abdelaziz, A.I, et al. (2024), DIAGNOSTIC METHODS AND DIAGNOSTIC ASSAY COMPRISING
DETECTION OF LNCRNAS, European Patent number: EP 4 379 064 A1, European Patent Office.
Patent publication number: EP 4 379 064 A1
European Patent Application: 22210144.6
Publication date: June 5, 2024
Applicants: University of Heidelberg and Newgiza University
Keywords: Classification of (cancer) disease, therapy monitoring and identification of risk groups by long non-coding RNA (lncRNA) signatures in blood serum of patients (36-21PRIO)
Status: Granted
Awards:
- Alexander Von Humboldt – Renewed Research Stay – awarded to Prof. Ahmed Ihab, School of Medicine, Germany 2023-2024.
- Membership of the WHO Panel of Experts who will inform the development of the WHO Collective Global Network for Rare Diseases (WHO CGN4RD) 2021.
- Membership of the Egyptian reference Genome project 2020.
- Alexander Von Humboldt – Georg Forster Research Fellowship for postdoctoral researchers – awarded to Dr. Nada El-Ekiaby, School of Medicine, 2019
- Alexander Von Humboldt – Georg Forster Research Fellowship for experienced researchers – awarded to Prof. Ahmed Ihab, School of Medicine, Germany 2017.
- State Encouragement Award: Advanced Technological Medical Sciences by the Academy of Scientific Research and Technology (ASRT) 2015.
- Delegate membership of the DAAD selection committee for MSc. & PhD. Candidates for studying in Germany.
Workshops and Conferences:
- Neuromuscular Genetic Congress, November 2022.
The NMGC was held at NewGiza University’s campus, in partnership with Myo-Care National Foundation, scientifically endorsed by the World Muscle Society, sponsored by the World Muscle Society and Genpharm, supported by Pfizer Inc. under the Independent Medical Educational Agreement. The meeting had hosted national and international expertise in Neuroscience and Human Genetics to provide an educational setup for neurologists, geneticists, pediatricians, pulmonologists, physiotherapists, nutritionists, and postgraduate students interested in neuro-muscular genetics in our region.
- Translational Research Seminar Series IV – Back to the Future: Biomedicine beyond the Normal Tradition, February 2023.
In cooperation between SOM at NGU and Biology department at AUC, translational medicine seminar took place within the premises of NGU campus, it encompasses different advanced scientific disciplines such as: Molecular Cardiology, Molecular Oncology, Molecular Neurology, Proteomics, Genomics, Transcriptomics, Molecular Genetics in Pediatrics, Molecular Hepatology, Molecular Microbiology, Metagenomics, Metabolomics, Pharmacogenetics, and their impact on health medical sciences.
- DMD Educational Course, November 2024.
This course took place in November 2024, at NGU’s main campus and community hospital. The course is supported by Pfizer Inc. under the Independent Medical Educational Agreement and will be executed in the form of 4 intensive days. In the form of a two-day lecture series, delivered by distinguished medical professionals specialized in muscular dystrophies, human geneticists, and biomedical scientists then following the lectures, participants will engage in a two-day workshop at the Myo-Care Foundation clinic (community hospital clinic).





SOM code of conduct
Publications

SOM Journal Publications (2016- August 2025)
Listed as follows:
1. Impact of tailored diabetes education on adherence and glycemic control in children and
adolescents on continuous subcutaneous insulin infusion, prospective interventional
study in a tertiary center Hassan, M., ElHelaly, M., Badawi, N. et al. BMC Pediatr 25, 670
(2025). https://doi.org/10.1186/s12887-025-06018-4
2. Development and Implementation of the International AIDA Network Castleman’s
Disease Registry.” Vitale, Antonio, et al. (2025). Frontiers in Medicine 12: 1579182.
Lithy, R., Kohla, M., Dabees, H. et al. Sorafenib-treated hepatocellular carcinoma with or
without prior direct-acting antiviral therapy for hepatitis C: outcomes and survival. Egypt
Liver Journal 15, 47 (2025). https://doi.org/10.1186/s43066-025-00448-6
3. Empagliflozin attenuates pyroptosis by regulating thioredoxin-NLRP3 inflammasome
axis in a high fat cholesterol diet/streptozotocin model of atherosclerosis. Hendawy,
Nevien, et al. Journal of Pharmacy and Pharmacology (2025): rgaf051.
4. Comparing long-term nasal projection and rotation outcomes in rhinoplasty: a
systematic review and meta-analysis of columellar strut graft versus septal extension
graft. Mahmoud, Y., Jabrieh, G., Dawoud, H. et al. Eur J Plast Surg 48, 62 (2025).
https://doi.org/10.1007/s00238-025-02321-6
5. Outcomes of Cross-Leg Flap Use in Lower Limb Salvage in Resource-Limited Settings: A
Systematic Review of Indications, Limitations, and Success Rates. Ibrahim, Abdelrahman,
et al. “” Cureus 17.7 (2025).
6. Barriers to Implementation of Clinical Trial Findings in Pain Management: A Systematic
Review Hamdi, Yara, et al. “.” APHA 2025 Annual Meeting and Expo. APHA, 2025.
7. Depression Among Neurologists in Egypt: A Growing Concern in Medical Practice-A cross
sectional study. Nasef, Maram Samy, Sara Abozeid, and Saifeldin A. Hassan. (2025).
8. Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in
VEXAS syndrome: data from the international AIDA Network VEXAS registry. Vitale,
Antonio, et al. Frontiers in Pharmacology 16 (2025): 1462254.
9. The Objective Structured Long Examination Record (OSLER) as a Tool for Formative
Assessment of Clinical Competency: Analysis of Students’ Perceptions and Performance
Foda H, Hossameldin M, Adel A, Mohsen L. World Journal of Medical education and
Research. WJMER, Vol 30: Issue 1, 2025, 26-34
10. COVID-19 safe dental practices among a group of Egyptian students: a cross-sectional
study Abozaid, D.A., Hamed, D., Hindy, K.M. et al. Antimicrob Resist Infect Control 14, 73
(2025). https://doi.org/10.1186/s13756-025-01591-w
11. Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies
of advanced HCC with lower survival in non-viral patients. Barakat, Eman MF, et al.
Scientific Reports 15.1 (2025): 20323.
12. Efficacy of Hyperbaric Oxygen Therapy as an Adjunct in Aesthetic Surgery: A Systematic
Review and Meta-analysis of Postoperative Outcomes and Complications.Mortada,
Hatan, et al. Aesthetic Plastic Surgery (2025): 1-15.
13. Impact of differential detection of TM6SF2 rs58542926 mutation in circulating tumor
DNA versus peripheral blood cells on hepatocellular carcinoma patients Youssef, Samar
Samir, et al. “.” Discover Oncology 16.1 (2025): 1071.
14. Discrepancy in Myocardial Responses to Pressure Overload versus Volume Load Lesions.
AbdelMassih, Antoine Fakhry; Gomaa, Fatma AlZahraa Mostafa; Mouhareb, Nermin; Diab,
Nourine; Helmy, Rasha. Journal of Cardiovascular Echography 35(1):p 50-54, Jan–Mar
2025. | DOI: 10.4103/jcecho.jcecho_72_24
15. Diabetic foveal neovascularization is associated with diminished subfoveal choroidal
flow on optical coherence tomography angiography. Fayed, A.E., Gabra, M.A., Fikry, R.R.
et al. Eye 39, 2169–2175 (2025). https://doi.org/10.1038/s41433-025-03806-1
16. Vaccines for Alzheimer’s disease: a brief scoping review. Serag, Ibrahim, et al.
Neurological Sciences (2025): 1-26.
17. Impact of HLA-B51 on uveitis and retinal vasculitis: data from the AIDA International
Network Registries on ocular inflammatory disorders Sota, Jurgen, et al. “.” Ocular
immunology and inflammation 33.1 (2025): 48-55.
18. Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS
syndrome: real-world data from the international AIDA network. Vitale, Antonio, et al.
Frontiers in Pharmacology 16 (2025): 1539756.
19. Characteristics and survival of patients with viral versus nonviral associated
hepatocellular carcinoma: a multicenter cohort study. El-Kassas, Mohamed, et al.
European Journal of Gastroenterology & Hepatology 37.1 (2025): 83-93.
20. Adalimumab monotherapy or combination therapy with methotrexate in paediatric
uveitis: data from the AIDA Network Uveitis Registry. Gaggiano, Carla, et al. Clinical &
Experimental Ophthalmology (2025).
21. Foodborne Pathogens and Disease. Yehia, Hany M., et al. ” (2025).
22. Prevalence of Flesh-Eating Bacteria (Vibrio Vulnificus) Type A (Environmental) and Type
B (Clinical) in Tilapia Fish Samples: Phenotypic and Molecular Characterizations.
Moawad, Mostafa Hossam El Din, et al. “Safety and efficacy of intravenous thrombolysis:
a systematic review and meta-analysis of 93,057 minor stroke patients.” BMC neurology
25.1 (2025): 33.
23. Adherence to oral and topical medications among dermatology patients. Abdel Hay,
Rania Mounir, et al. “” Archives of Dermatological Research 317.1 (2025): 609.
24. Development and implementation of the international AIDA network spondylarthritis
registry. Caggiano, Valeria, et al. “” Frontiers in Medicine 12 (2025): 1509357.
25. APOE genetic variability in an Egyptian cohort of PD. Khedr, Eman M., et al. “.” Frontiers
in Neuroscience 19 (2025): 1579968.
26. Influence of gender on Behçet’s disease phenotype and irreversible organ damage: Data
from the International AIDA Network Behçet’s Disease Registry.”Sota, Jurgen, et al. ”
Joint Bone Spine 92.2 (2025): 105819.
27. “The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A
Systematic Review.” Zakaria, Fady, et al. 2025Molecular diagnosis & therapy.
28. How Does Maternal Lipopolysaccharide Exposure Impact Prenatal Testicular
Development in Rats, and Could α-Tocopherol Provide a Protective Effect? A
Histological, Immunohistochemical and Biochemical Study. Fareed, Shimaa Antar, et al.
“.” Birth Defects Research 117.5 (2025): e2469.
29. Leading Role of Sofosbuvir/Daclatasvir in Achieving Hepatitis C Elimination in Egypt.
Elbaz, Tamer, et al. “” Journal of Viral Hepatitis 32.7 (2025): e70032.
30. Role of neuromuscular ultrasound in the evaluation of amyotrophic lateral sclerosis.
Elwan, Sherif Hassan, et al. “” The Egyptian Journal of Neurology, Psychiatry and
Neurosurgery 61.1 (2025): 20.
31. Impact of Access Site in Percutaneous Coronary Intervention for Patients Complicated
with Cardiogenic Shock: A Systematic Review and Meta-Analysis of 33,311 Individuals.
Larik, Muhammad Omar, et al. “” Catheterization and Cardiovascular Interventions (2025).
32. Tissue and serum levels of substance P in trichodynia of androgenetic alopecia patients.
Gohary, Yasser M.a; Shaker, Olfat G.b; Elshimy, Lina A.c; Osman, Shimaa T.a. Journal of the
Egyptian Women’s Dermatologic Society 22(1):p 22-28, January-April 2025. | DOI:
10.4103/jewd.jewd_7_24
33. Effect of Inhalation Aromatherapy on Patients Undergoing PCI Angiography: A
Systematic Review and Meta-analysis Elsaid, Mohamed, et al. “.” Advances in Integrative
Medicine (2025).
34. Heart rate variability stands up to bedside tests and composite autonomic symptom
score-31 (COMPASS-31) questionnaire: Diagnostic tools for autonomic dysfunction in
systemic sclerosis patients Maghraby, Gehad G., et al. “.” The Egyptian Rheumatologist
47.1 (2025): 41-45.
35. Diagnostic Accuracy of Magnetic Resonance Imaging in the Diagnosis of Placenta
Accreta Spectrum: A Systematic Review and Meta-analysis. AbdelAziz, Suzi, et al. ”
Maternal-Fetal Medicine 7.01 (2025): 15-21.
36. Increased risk of non-cancer deaths in patients with malignant brain tumors:
observations from the SEER database Ashry, M.H., Sadeq, M.A. & Afify, A.Y.. Egypt J
Neurosurg 40, 49 (2025). https://doi.org/10.1186/s41984-025-00350-8
37. MEIS1: From functional versatility to post-transcriptional/translational regulation.
Fahim, Salma A., et al. “” Life Sciences (2025): 123683. Review
38. Tissue and serum levels of Substance P in trichodynia of androgenetic alopecia patients,
Gohary, Yasser M.; Shaker, Olfat G.; Elshimy, Lina A.; Osman, Shaymaa T., 2025, Journal of
the Egyptian Women’s Dermatologic Society
39. Drug repurposing of argatroban, glimepiride and ranolazine shows anti-SARS-CoV-2
activity via diverse mechanisms. Shereen A. El Sobky, Injie O. Fawzy, Mahmoud S. Ahmed,
Manon Ragheb, Merna H.M. Hamad a, Rowan Bahaaeldin a, Salma A. Fahim, Rana Saad,
Ziad A. Khalil, Sara H. Mahmoud, Ahmed Mostafa, Mohamed A. Ali, Hesham A. Sadek,
Nada El-Ekiaby, Ahmed I. Abdelaziz. Heliyon 2025 Feb,
https://doi.org/10.1016/j.heliyon.2025.e41894. PMID:
40. Characteristics and survival of patients with viral versus non-viral associated
hepatocellular carcinoma: a multicenter cohort study. El-Kassas M, Barakat EMF,
Shousha HI, Kohla M, Said M, Moustafa EF, Tawheed A, Shamkh MAA, Nabeel MM,
Elkhateeb E, Dabees H, Abdelmalek MO, Sayed H, Abdallah NM, Elbaz T, Rewisha E, Nassief
A, Riad AR, Sweedy AT, Askar SR, Abdelmaksoud AH, Gaber Y, Eysa B, Shaker M, Hashem
MB, Kaddah M, Radwan H, Hassan MS, Lithy R, AbouElmaaty ME, Abo-Elazm OM,
Abdelaziz AO; representing The Egyptian Network for the Study of HCC (ENSH) group. Eur
J Gastroenterol Hepatology 2025 doi: 10.1097/MEG.0000000000002870. Epub 2024 Nov
27. PMID: 39621880.
41. The Role of High-Resolution Ultrasound in the Diagnosis of Nerve Trauma New
Perspective: A Preliminary Systematic Review and Meta-Analysis of the Recent
Evidence. Aboutaleb AM, Abouelatta E, Salem T, Ibrahim AI, Serour AS, Abbas NB, Youssef
RA, Ballut OO, Shehta RI, Awad MW, Hassan KW, Abdelrhem HAH, Ali M, Badr M, Aref
SSM, Bedewi MA, Mohamed KA, Axer H, Abdelnaby R.J Clin Neurophysiol. 2025 Feb
1;42(2):101-106. doi: 10.1097/WNP.0000000000001126. Epub 2024 Nov 12.PMID:
39531287 Review.
42. MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells. Abdelbary R, Ragheb
M, El Sobky SA, El-Badri N, Aboud N, Tawheed A, Gomaa A, Zidan M, Aziz RK, Abouzid AE,
Salah RA, El-Kassas M, Waked I, Moustafa A, Fawzy IO, El-Ekiaby N, Abdelaziz AI.Front
Oncol. 2025 Jan 21;14:1523068. doi: 10.3389/fonc.2024.1523068. eCollection
2024.PMID: 39906666 Free PMC article.
43. Eccrine syringofibroadenoma and amyloidosis cutis dyschromica: A new association.
Indian J Dermatol Venereol Leprol. Published online January 21, 2025.
doi:10.25259/IJDVL_1423_2024
44. The clinical assessment of lung involvement in patients with Still’s disease, results from
the multicentre international AIDA Network Still’s Disease Registry. Ruscitti P, Vitale A,
Di Cola I, Caggiano V, Palumbo P, Di Cesare E, Hinojosa-Azaola A, Torres-Ruiz J, GuarachaBasañez GA, Martín-Nares E, Lopalco G, Morrone M, Iannone F, Giardini HAM, Cordeiro
RA, de Brito Antonelli IP, Berardicurti O, Navarini L, Ciccia F, Visconti MC, Iacono D,
Direskeneli H, Erten S, Yao H, Thabet M, Tharwat S, Ragab G, Gómez-Caverzaschi V, Sfikakis
PP, Fotis L, La Torre F, Maier A, Karamanakos A, Almaghlouth IA, Frassi M, Tufan A, Govoni
M, Sota J, Simonini G, Emmi G, Li Gobbi F, Parronchi P, Costi S, Sarzi-Puttini P, Opris-Belinski
D, Sfriso P, Tarsia M, Maggio MC, Monti S, Gündüz ÖS, Rigante D, Bartoloni E, Verrecchia
E, Iagnocco A, Viapiana O, Bargagli E, Batu ED, Sebastiani GD, Del Giudice E, Conti G, Breda
L, Gidaro A, Gicchino MF, Gaggiano C, Brucato AL, Triggianese P, Makowska J, Carubbi F,
Farina N, Guggino G, De Paulis A, Mazzei MA, Di Meglio N, Lo Gullo A, Conforti A, Ogunjimi
B, Calabrese L, Rubegni P, Giardina A, Wiesik-Szewczyk E, Balistreri A, Fabiani C, Frediani
B, Dagna L, Giacomelli R, Cantarini L.Rheumatology (Oxford). 2025 Jan 20:keaf021. doi:
10.1093/rheumatology/keaf021. Online ahead of print.PMID: 39832276
45. Interaction Between Malat1 and miR-499-5p Regulates Meis1 Expression and Function
with a Net Impact on Cell Proliferation. Fahim SA, Ragheb M, Fayed IH, Osama A, Karam
A, Magdeldin S, Metwale R, Elsayed MDAA, Abdellatif A, Sadek HA, El Sobky SA, El-Ekiaby
N, Fawzy IO, Abdelaziz AI.Cells. 2025 Jan 16;14(2):125. doi: 10.3390/cells14020125.PMID:
39851553 Free PMC article.
46. Berberine chloride loaded nano-PEGylated liposomes attenuates imidacloprid-induced
neurotoxicity by inhibiting NLRP3/Caspase-1/GSDMD-mediated pyroptosis. El Gazzar
WB, Farag AA, Samir M, Bayoumi H, Youssef HS, Marei YM, Mohamed SK, Marei AM,
Abdelfatah RM, Mahmoud MM, Aboelkomsan EAF, Khalfallah EKM, Anwer HM.Biofactors.
2025 Jan-Feb;51(1):e2107. doi: 10.1002/biof.2107. Epub 2024 Jul 29.PMID: 39074847
47. Evaluation of Myocarditis in Patients with Still Disease: Clinical Findings From the
Multicenter International AIDA Network Still Disease Registry. Ruscitti P, Di Cola I, Vitale
A, Caggiano V, Palumbo P, Di Cesare E, Torres-Ruiz J, Guaracha-Basañez GA, Martín-Nares
E, Ciccia F, Iacono D, Riccio F, Maggio MC, Tharwat S, Hashad S, Rigante D, Ortolan A,
Mayrink Giardini HA, de Brito Antonelli IP, Cordeiro RA, Giacomelli R, Navarini L,
Berardicurti O, Conforti A, Opris-Belinski D, Sota J, Gaggiano C, Lopalco G, Iannone F, La
Torre F, Mastrorilli V, Govoni M, Ruffilli F, Emmi G, Biancalana E, Sfikakis PP, Tektonidou M,
Hernández-Rodríguez J, Gómez-Caverzaschi V, Gündüz ÖS, Conti G, Patroniti S, Gidaro A,
Bartoli A, Olivieri AN, Gicchino MF, Brucato AL, Dagna L, Tomelleri A, Campochiaro C, De
Paulis A, Mormile I, Della Casa F, Direskeneli H, Alibaz-Oner F, Karamanakos A, Dimouli A,
Ragab G, Mahmoud AAA, Tufan A, Kucuk H, Kardas R, Batu ED, Ozen S, Wiesik-Szewczyk E,
Hinojosa-Azaola A, Balistreri A, Fabiani C, Frediani B, Cantarini L; International AIDA
Network and the Autoinflammatory Diseases Working Group of the Italian Society of
Rheumatology.J Rheumatol. 2025 Jan 15 :jrheum.2024-0683. doi: 10.3899/jrheum.2024-
0683. Online ahead of print. PMID: 39547690
48. Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International
Network Registries on Ocular Inflammatory Disorders. Sota J, Guerriero S, Lopalco G,
Tufan A, Ragab G, AlMaglouth I, Govoni M, Sfikakis PP, Frassi M, Vitale A, Kardas RC,
Triggianese P, Chimenti MS, Aboabat AA, Piga M, Monti S, Sebastiani GD, Yildirim D,
Conforti A, Gentileschi S, Dammacco R, Hinojosa-Azaola A, Kawakami-Campos PA, Ruffilli
F, Torres-Ruiz J, Thabet M, Atig A, Ruscitti P, Cataldi G, Viapiana O, Hatemi G, Karakoç A,
Costi S, Iagnocco A, Crisafulli F, Fragoulis G, Del Giudice E, Hegazy MT, Paroli MP, Şahin A,
Morrone M, Iannone F, Opris-Belinski D, Asfina KN, Barone P, Gaggiano C, Kucuk H,
Gicchino MF, Carubbi F, Caggiano V, Laskari K, Tharwat S, Direskeneli H, Alibaz-Oner F,
Sevik G, Maier A, Laymouna AH, Emmi G, Akkoç N, Tarsia M, Sbalchiero J, Conti G, Spinella
R, La Torre F, Tombetti E, Amin RH, Mauro A, Karamanakos A, Carreño E, Fonollosa A,
Cattalini M, Breda L, de-la-Torre A, Wiesik-Szewczyk E, Cifuentes-González C, Ozen S,
Mazzei MA, Tosi GM, Frediani B, Balistreri A, Batu ED, Gupta V, Cantarini L, Fabiani C.Ocul
Immunol Inflamm. 2025 Jan;33(1):48-55. doi: 10.1080/09273948.2024.2346815. Epub
2024 May 17.PMID: 38759215
49. Incidence and Risk Factors of Delirium After Neurointerventions: A Systematic Review
and Meta-Analysis. H. Atwan, Z. M. Wesh, S. Sherif Mohamed Aref, A. Moustafa
Aboutaleb, F. Abdelkhalig Salih Mukhtar, R. Ahmed Youssef, K. Ashraf Mohamed, and R.
Abdelnaby. 2025. American heart association journal,
https://doi.org/10.1161/SVIN.04.suppl_1.113
50. Epigenetic alterations of miR-155 and global DNA methylation as potential mediators of
ochratoxin A cytotoxicity and carcinogenicity in human lung fibroblasts. Kharboush TG,
Ahmed IA, Farag AA, Kharboush T, Sayed AEH, Abdel-Kareim AM, Al Mohaini M, Attia H,
Eid RA, Zaki MSA, Al- Tabbakh AM. Environ Sci Pollut Res Int. 2024 Jan;31(4):5473-5483.
doi: 10.1007/s11356-023- 31283-0.
51. Introducing a Synchronous Workshop Feedback Model for OSCE Development in an
International Education Partnership Gondhalekar, A., Arfeen, Z., Mohsen, L. et al.
Med.Sci.Educ. 34, 1305–1308 (2024). https://doi.org/10.1007/s40670-024-02136-3
52. “Students’ Perception of the Portfolio as a Method of Teaching and learning Assessment
in the Newly Established Egyptian Medical Program.” Salah El Din, Rania A., Soha Ashry,
and Ansam Seif. Educational Research and Innovation Journal 4.14 (2024): 1-15.
53. Empowering cancer prevention with AI: unlocking new frontiers in prediction, diagnosis,
and intervention. Dafni MF, Shih M, Manoel AZ, Yousif MYE, Spathi S, Harshal C, Bhatt G,
Chodnekar SY, Chune NS, Rasool W, Umar TP, Moustakas DC, Achkar R, Kumar H, Naz S,
Acuña-Chavez LM, Evgenikos K, Gulraiz S, Ali ESM, Elaagib A, Uggh IHP.Cancer Causes
Control. 2024 Dec 13. doi: 10.1007/s10552-024-01942-9. Online ahead of print.PMID:
39672997 Review.
54. Corneal ECC Biomechanics Parameters after Different Laser Vision Correction
Procedures. Mohamed Hosny, Wessam Salem, Mohamed Anis, Tarek el Naggar, 2024,
International Keratoconus and Ectatic disease journal
55. Correlating DNMT1, PCNA, and RB1 genes as new prognostic biomarkers, Reham F.
Othman, 2024 Egyptian journal of cancer and biomedical research,
DOI: 10.21608/JCBR.2024.252496.1325
56. Diagnostic utility of testosterone priming prior to dynamic tests to differentiate
constitutional delay in puberty from isolated hypogonadotropic hypogonadism in boys,
Shimaa Medhat Abdellatif Ahmed, Nora ElSaid Badawi, Mohamed Ahmed AbdElSalam,
Lubna Fawaz, AbdelKarim Kamel, and Mona Mamdouh Hassan, 2024, Egyptian Pediatric
Association Gazette (2024) 72:84, https://doi.org/10.1186/s43054-024-00324-9
57. Assessment of the Menstrual Cycle and Its Effect on Glycemic Control in a Sample of
Egyptian Adolescent Females with Type 1 Diabetes: A Clinical Prospective Study,
Shahenda Shaaban Ismail, Nora El Sayed Badawi, Samah Ahmed Hassanein, Eman Hany El
Sebaie, Marwa Farouk Mira, Mona Mamdouh Hassan, 2024, Clinical Diabetology, Vol 13,
No 4
58. Interaction between HOTTIP, H19, and HOTAIR long noncoding RNAs and miRNA-152 in
cases of HCC caused by HCV infection. Reham F. Othman, 2024 Beni-Suef University
Journal of Basic and Applied Sciences, https://doi.org/10.1186/s43088-024-00499-5
59. Sarcopenia and low prognostic nutritional index as markers of disease activity in
patients with inflammatory bowel disease and predictors of poor outcome: a cohort
longitudinal study. Sherif M, Fouad R, Elbaz T, Awadalla M, Tantawi O, Negm M, El-kareem
DA, Naguib I, Shehab H, Badary HA. 2024 Egyptian Rheumatology and Rehabilitation.
https://doi.org/10.1186/s43166-024-00289-y
60. Renal registry for chronic kidney disease patients in Egypt: causes and comorbidities,
data from a private clinic in an urban area. Gawad, Mohamed A; Yousri, Noura Mohamed;
Hammad, Mohamed. 2024. Journal of The Egyptian Society of Nephrology and
Transplantation, DOI: 10.4103/jesnt.jesnt_21_23
61. NephroConnect: Patterns, preferences, barriers, and potentials in the global nephrology
community’s social media landscape, Sibel G. Bek, Sabine Karam, Daniel P. Murphy, José
A. Moura-Neto, Sibel Balcı, Mohammed A. Gawad, Rolando Claure-Del Granado, Namrata
Parikh, Basu Gopal, Manju Yadla, Elliot Tannor, Yannick Nlandu, Didem Turgut, Xavier V.
Parada, Ahmed Akl , Augusto Cesar Soares dos Santos Junior, Fernanda Arce-Amare,
Urmila Anandh, Edgar Lerma, Jyoti Baharani, 2024, Kidney International Reports, DOI:
10.1016/j.ekir.2024.04.009
62. The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated
lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients.
Mohamed Adel Abd Elaziz,Asmaa Mustafa Gouda Elewa,Dina Zaki Mohamed Zaki Abdel
Hamid,Nohier Essam Soliman Ahmed Hassan,Éva Csongrádi,Emad Hamdy Hamouda
Mohammed &Mohammed Abdel Gawad, 2024 Renal Failure, DOI:
10.1080/0886022X.2024.2346284
63. Depression, anxiety, and low quality of sleep among Egyptian hemodialysis patients: a
single-center study, Gawad, Mohammed Abdel; Hosny, Mohamed; Ayoub, Mohamed;
Elnahrawy, Radwa Saeed; Soultan, Mona; Yasser, Mahmoud; Mahdy, Eman, 2024, Journal
of The Egyptian Society of Nephrology and Transplantation, DOI:
10.4103/jesnt.jesnt_24_24
64. The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated
lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients. Abd
Elaziz MA, Mustafa Gouda Elewa A, Zaki Mohamed Zaki Abdel Hamid D, Essam Soliman
Ahmed Hassan N, Csongrádi É, Hamdy Hamouda Mohammed E, Abdel Gawad M. Ren Fail.
2024 Dec;46(1):2346284. Doi: 10.1080/0886022X.2024.2346284. PMID: 38757700
65. Invited Response on: Effectiveness and Role of Using Hyaluronic Acid Injections for
Gluteal Augmentation: A Comprehensive Systematic Review of Techniques and
Outcomes. Mortada H, Alkadi D, Saqr H.Aesthetic Plast Surg. 2024 Dec;48(23):5249-5250.
doi: 10.1007/s00266-023-03806-0. Epub 2024 Jan 9.PMID: 38195899 No abstract
available.
66. Factors Affecting Outcomes After Free Functional Gracilis Muscle Transfer for Elbow
Flexion in Brachial Plexus Injury: A Systematic Review and Meta-Analysis. Ahmed SH,
Shekouhi R, Husseiny YM, Rios E, Sohooli M, Chim H.J Hand Surg Am. 2024
Dec;49(12):1173-1185. doi: 10.1016/j.jhsa.2024.07.012. Epub 2024 Sep 2.PMID:
39230552
67. Evaluation of tumorigenesis-related miRNAs in breast cancer in Egyptian women: a
retrospective, exploratory analysis. Salum GM, Elaraby NM, Ahmed HA, Abd El Meguid
M, Fotouh BE, Ashraf M, Elhusseny Y, Dawood RM.Sci Rep. 2024 Nov 29;14(1):29757. doi:
10.1038/s41598-024-68758-0.PMID: 39614097 Free PMC article.
68. Influence of gender on Behçet’s disease phenotype and irreversible organ damage: Data
from the International AIDA Network Behçet’s Disease Registry. Sota J, Ragab G,
AlMaglouth I, Lopalco G, Tufan A, Direskeneli H, Hinojosa-Azaola A, Mayrink Giardini HA,
Guerriero S, Triggianese P, Sfikakis PP, Piga M, Ruscitti P, Govoni M, Iagnocco A, Carubbi F,
Hernández-Rodríguez J, Laymouna AH, Mahmoud AAA, Ghanema M, Aboabat AA, Asfina
KN, Alanazi F, Morrone M, Spedicato V, Kucuk H, Kardas R, Alibaz Öner F, Sevik G, TorresRuiz J, Kawakami-Campos PA, Parente de Brito Antonelli I, Dammacco R, Chimenti MS,
Arida K, Floris A, Gentile M, Ruffilli F, Bellis E, Alunno A, Espinosa G, Gentileschi S, Gaggiano
C, Vitale A, Caggiano V, Lopez R, Tarsia M, Monti S, Hatemi G, Karakoç A, Frassi M,
Giacomelli R, Tharwat S, Thabet M, Ciccia F, Emmi G, Viapiana O, Şahin A, Sebastiani GD,
Batu ED, Ozen S, Sener S, Opris-Belinski D, Costi S, Conforti A, Cattalini M, Bartoloni E,
Akkoç N, Gunduz OS, Conti G, Maier A, Giardina A, Li Gobbi F, Parronchi P, Sarzi Puttini P,
Breda L, De Paulis A, Carreño E, La Torre F, Więsik-Scewczyk E, de-la Torre A, Mejía-Salgado
G, Shahram F, Guiducci S, Maggio MC, Aragona E, Rigante D, Ciavarro A, Önen F, Erten Ş,
Insalaco A, Del Giudice E, Barone P, Gicchino F, Brucato A, Lo Gullo A, Mauro A,
Karamanakos A, Balistreri A, Maz…See abstract for full author list ➔Joint Bone Spine. 2024
Nov 15;92(2):105819. doi: 10.1016/j.jbspin.2024.105819. Online ahead of print.PMID:
39549971 Free article
69. Characteristics and survival of patients with viral versus nonviral associated
hepatocellular carcinoma: a multicenter cohort study. El-Kassas M, Barakat EMF, Shousha
HI, Kohla M, Said M, Moustafa EF, Tawheed A, Shamkh MAA, Nabeel MM, Elkhateeb E,
Dabees H, Abdelmalek MO, Sayed H, Abdallah NM, Elbaz T, Rewisha E, Nassief A, Riad AR,
Sweedy AT, Askar SR, Abdelmaksoud AH, Gaber Y, Eysa B, Shaker M, Hashem MB, Kaddah
M, Radwan H, Hassan MS, Lithy R, AbouElmaaty ME, Abo-Elazm OM, Abdelaziz AO;
representing The Egyptian Network for the Study of HCC (ENSH) group.Eur J Gastroenterol
Hepatol. 2025 Jan 1;37(1):83-93. doi: 10.1097/MEG.0000000000002870. Epub 2024 Nov
27.PMID: 39621880
70. Pulse azathioprine and low-dose methotrexate vs. Standard-dose methotrexate in
treatment of patients with moderate-to-severe psoriasis: a randomized controlled trial
2024 (DOI: https://doi.org/10.1093/ced/llae078)
71. Inherited privilege? First vs. continuing-generation medical students in Egypt, academic
performance, extracurricular training and expectations: a cross-sectional study.
Aboudeif A, Elaraby Y, Hany M, Nasser S, Refaat N, Mohamed YG, Khalil RY, Khabiry H,
Raafat FH, Ghazy N, Boulos DNK, Yosef M.BMC Med Educ. 2024 Nov 6;24(1):1274. doi:
10.1186/s12909-024-06227-y.PMID: 39506796 Free PMC article.
72. Call for elimination program of Malaria among children under 5 years old living in
refugee camps in eastern Democratic Republic of Congo. Alhassan A, Ajala LS, Ode B,
Alanjiro M, Rehman S, Onesime J, Kihanduka E, Tague C, Farhan K, Banga S, Rugendabanga
E, Manga A, Mbwambo GJ, Hangi S, Rhugendabanga F, Mufungizi I, Furqan M, Rusho MA,
Budair MM, Akilimali A; Medical Research Circle Collaborators.New Microbes New Infect.
2024 Oct 11;62:101508. doi: 10.1016/j.nmni.2024.101508. eCollection 2024 Dec.PMID:
39497915 Free PMC article. Review.
73. A single-center experience in home management of mild and moderate COVID-19 cases.
Hegazy MT, Abdel-Hamid HM, Salem AA, Nagy F, Rizk SE, Abd El Wahab H, Naguib I, El
Assaly H, Farwaela HM, Morad MA, Mortagy M, Attia H, Elebrashy I, Mattar M, Ibrahim
MHE.J Infect Dev Ctries. 2024 Sep 30;18(9.1):S176-S183. doi: 10.3855/jidc.19243.PMID:
39499762 Free article.
74. OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix
proteoglycan decorin in hepatocellular carcinoma. Assal RA, Abd El-Bary RBE, Youness
RA, Abdelrahman MM, Zahran H, Hosny KA, Esmat G, Breuhahn K, El-Ekiaby N, Fawzy IO,
Abdelaziz AI.BMC Gastroenterol. 2024 Sep 30;24(1):337. doi: 10.1186/s12876-024-03413-
6.PMID: 39350070 Free PMC article.
75. Sex differences in survival outcomes of early-onset colorectal cancer. Afify AY, Ashry MH,
Hassan H.Sci Rep. 2024 Sep 26;14(1):22041. doi: 10.1038/s41598-024-71999-8.PMID:
39327445 Free PMC article.
76. Effect of Placental Derived Nucleoproteins on liver regeneration in DEN-induced liver
fibrosis model. Nasr SM, Hassan M, Abou-Shousha T, Elhusseny Y, Elzallat M.Biomed
Pharmacother. 2024 Sep; 178:117190. doi: 10.1016/j.biopha.2024.117190. Epub 2024 Jul
26. PMID: 39067160 Free article.
77. A novel homozygous nonsense variant in COL12A1 causes myopathic Ehlers-Danlos
syndrome: A case report and literature review.” Neuropathology and applied
neurobiology. El Sherif, R., Saito, Y., Hussein, R. S., Izu, Y., Koch, M., Noguchi, S., & Nishino,
I. 2024 Aug vol. 50,4: e13004. https://doi.org/10.1111/nan.13004 Review
78. Letter to the Editor Regarding “Outcomes of Intramuscular Gluteal Augmentation with
Implants Using Tumescent Local Anesthesia”. Saqr H, El Fahar MH.Aesthetic Plast Surg.
2024 Sep;48(17):3550-3551. doi: 10.1007/s00266-023-03585-8. Epub 2023 Aug 28. PMID:
37639025 No abstract available.
79. Rosacea, a rare cutaneous adverse effect of antitumor necrosis factor alpha
medications: a case report and review of the literature 2024 (DOI:
https://doi.org/10.1111/ijd.16881).
80. Secondary azoospermia after a successful natural pregnancy: a primary prospective
study. Elahwany A, Alahwany H, Torad H, Ramzy D, Aboelkomsan EAF, GamalEl Din SF.Basic
Clin Androl. 2024 Aug 6;34(1):12. doi: 10.1186/s12610-024-00227-0.PMID: 39103792
Free PMC article.
81. Introducing a Synchronous Workshop Feedback Model for OSCE Development in an
International Education Partnership. Gondhalekar A, Arfeen Z, Mohsen L, Shabrawy ME,
Mokhtar H, Rashid MA.Med Sci Educ. 2024 Aug 29;34(6):1305-1308. doi: 10.1007/s40670-
024-02136-3. eCollection 2024 Dec.PMID: 39758483 Free PMC article.
82. Role of cell-free DNA levels in the diagnosis and prognosis of sepsis and bacteremia: A
systematic review and meta-analysis. Dadam MN, Hien LT, Makram EM, Sieu LV, Morad
A, Khalil N, Tran L, Makram AM, Huy NT.PLoS One. 2024 Aug 29;19(8):e0305895. doi:
10.1371/journal.pone.0305895. eCollection 2024.PMID: 39208340 Free PMC article.
83. Introducing a Synchronous Workshop Feedback Model for OSCE Development in an
International Education Partnership. Gondhalekar A, Arfeen Z, Mohsen L, Shabrawy ME,
Mokhtar H, Rashid MA.Med Sci Educ. 2024 Aug 29;34(6):1305-1308. doi: 10.1007/s40670-
024-02136-3. eCollection 2024 Dec.PMID: 39758483 Free PMC article.
84. AI chatbots show promise but limitations on UK medical exam questions: a comparative
performance study. Sadeq MA, Ghorab RMF, Ashry MH, Abozaid AM, Banihani HA, Salem
M, Aisheh MTA, Abuzahra S, Mourid MR, Assker MM, Ayyad M, Moawad MHED.Sci Rep.
2024 Aug 14;14(1):18859. doi: 10.1038/s41598-024-68996-2.PMID: 39143077 Free PMC
article.
85. A novel homozygous nonsense variant in COL12A1 causes myopathic Ehlers-Danlos
syndrome: A case report and literature review. El Sherif R, Saito Y, Hussein RS, Izu Y, Koch
M, Noguchi S, Nishino I.Neuropathol Appl Neurobiol. 2024 Aug;50(4): e13004.
https://doi.org/10.1111/nan.13004 Review.
86. Management strategies and outcomes of thromboembolism prevention in atrial
fibrillation co-existing with immune thrombocytopenia: A review of evidence. Metwally
OH, Rahhal A, Elsherif RA, Elshoeibi AM, Elhadary M, Elshoeibi AM, Badr A, Elsayed B, AlRasheed M, Alshurafa A, Yassin MA.Int J Cardiol Heart Vasc. 2024 Aug 22;54:101493. doi:
10.1016/j.ijcha.2024.101493. eCollection 2024 Oct.PMID: 39263408 Free PMC article.
Review.
87. Multiple Erythematous Papules and Nodules on a Scalp: Challenge. Fawzy MM,
Abdelraouf SM, Korany MM.Am J Dermatopathol. 2024 Aug 1;46(8):e59-e60. doi:
10.1097/DAD.0000000000002730.PMID: 39028124 No abstract available.
88. Multiple Erythematous Papules and Nodules on a Scalp: Answer. Fawzy MM, Abdelraouf
SM, Korany MM.Am J Dermatopathol. 2024 Aug 1;46(8):545. doi:
10.1097/DAD.0000000000002731.PMID: 39028121 No abstract available.
89. In Vivo Ocular Pharmacokinetics and Toxicity of Siponimod in Albino Rabbits. Alshaikh
RA, Salah El Din RA, Zaki RGE, Waeber C, Ryan KB.Mol Pharm. 2024 Jul 1;21(7):3310-3320.
doi: 10.1021/acs.molpharmaceut.4c00063. Epub 2024 Jun 10.PMID: 38856116 Free PMC
article.
90. The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from
the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry. Ruscitti P,
Masedu F, Vitale A, Caggiano V, Di Cola I, Cipriani P, Valenti M, Mayrink Giardini HA, de
Brito Antonelli IP, Dagostin MA, Lopalco G, Iannone F, Maria M, Almaghlouth IA, Asfina
KN, Ali HH, Ciccia F, Iacono D, Pantano I, Mauro D, Sfikakis PP, Tektonidou M, Laskari K,
Berardicurti O, Dagna L, Tomelleri A, Tufan A, Can Kardas R, Hinojosa-Azaola A, MartínNares E, Kawakami-Campos PA, Ragab G, Hegazy MT, Direskeneli H, Alibaz-Oner F, Fotis L,
Sfriso P, Govoni M, La Torre F, Cristina Maggio M, Montecucco C, De Stefano L, Bugatti S,
Rossi S, Makowska J, Del Giudice E, Emmi G, Bartoloni E, Hernández-Rodríguez J, Conti G,
Nunzia Olivieri A, Lo Gullo A, Simonini G, Viapiana O, Wiesik-Szewczyk E, Erten S, Carubbi
F, De Paulis A, Maier A, Tharwat S, Costi S, Iagnocco A, Sebastiani GD, Gidaro A, Brucato
AL, Karamanakos A, Akkoç N, Caso F, Costa L, Prete M, Perosa F, Atzeni F, Guggino G,
Fabiani C, Frediani B, Giacomelli R, Cantarini L.Arthritis Rheumatol. 2024 Jul;76(7):1141-
1152. doi: 10.1002/art.42845. Epub 2024 May 15.PMID: 38499989
91. Clinical and molecular characterization of myotonia congenita using whole-exome
sequencing in Egyptian patients. Elaraby NM, Ahmed HA, Dawoud H, Ashaat NA, Azmy A,
Galal ER, Elhusseny Y, Awady HE, Metwally AM, Ashaat EA.Mol Biol Rep. 2024 Jun
15;51(1):766. doi: 10.1007/s11033-024-09646-8.PMID: 38877370
92. Differences in Clinicopathological Features, P16Ink4a and P57KIP2
Immunohistochemical Expressions, and Survival Between Colorectal Carcinoma in
Rectosigmoid and Other Colonic Locations. Elkhamisy FAA, Aboelkomsan EA, Foda
AAM.Cureus. 2024 Jun 10;16(6):e62061. doi: 10.7759/cureus.62061. eCollection 2024
Jun.PMID: 38989391 Free PMC article.
93. Safety and efficacy of continuous intrathecal baclofen via cervical catheter tip: a
retrospective case series. Mossner J, Abdelmageed S, Votoupal M, Misasi J, Saleh N,
Dziugan K, Krater T, Raskin JS. Neurosurg Focus. 2024 Jun;56(6):E13.
Doi: 10.3171/2024.3.FOCUS2475. PMID: 38823059
94. Melatonin counteracts polyethylene microplastics induced adreno-cortical damage in
male albino rats. Farag AA, Bayoumi H, Radwaan SE, El Gazzar WB, Youssef HS, Nasr HE,
Badr AM, Mansour HM, Elalfy A, Sayed AEH, Kharboush TG, Aboelkomsan EAF, Sliem RE,
Ecotoxicol Environ Saf. 2024 May 27; 279:116499. Doi: 10.1016/j.ecoenv.2024.116499.
Online ahead of print. PMID: 38805828
95. N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk
Inhibitors and Potential Anticancer Agents. Mostafa N, Chen PJ, Darwish SS, Su YC, Shiao
MH, Piazza GA, Abadi AH, Engel M, Abdel-Halim M.Cancers (Basel). 2024 May
27;16(11):2033. doi: 10.3390/cancers16112033.PMID: 38893153 Free PMC article.
96. A comparative study of different antiviral treatment protocols in HCV-related
cryoglobulinemic vasculitis. Allam WR, Hegazy MT, Hussein MA, Zoheir N, Quartuccio L,
El-Khamisy SF, Ragab G.Sci Rep. 2024 May 23;14(1):11840. doi: 10.1038/s41598-024-
60490-z.PMID: 38782988 Free PMC article.
97. Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights
from the SEER database. Afify AY, Ashry MH.Eur Arch Otorhinolaryngol. 2024
Aug;281(8):4409-4417. doi: 10.1007/s00405-024-08731-9. Epub 2024 May 22. PMID:
38775833 Free PMC article.
98. Cytoplasmic PPARγ Significantly Correlates With P53 Immunohistochemical Expression
and Tumor Size in Localized Tenosynovial Giant Cell Tumor. Elkhamisy FAA, Aboelkomsan
EA, Sallam MK, Eesa AN.Cureus. 2024 May 15;16(5):e60377. doi: 10.7759/cureus.60377.
eCollection 2024 May.PMID: 38882990 Free PMC article.
99. Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights
from the SEER database. Afify AY, Ashry MH. Eur Arch Otorhinolaryngol. 2024 May 22.
Doi: 10.1007/s00405-024-08731-9. Online ahead of print. PMID: 38775833
100. A comparative study of different antiviral treatment protocols in HCV related
cryoglobulinemic vasculitis. Allam WR, Hegazy MT, Hussein MA, Zoheir N, Quartuccio L,
El-Khamisy SF, Ragab G. Sci Rep. 2024 May 23;14(1):11840. Doi: 10.1038/s41598-024-
60490-z. PMID: 38782988
101. Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA
International Network Registries on Ocular Inflammatory Disorders. Sota J, Guerriero S,
Lopalco G, Tufan A, Ragab G, AlMaglouth I, Govoni M, Sfikakis PP, Frassi M, Vitale A, Kardas
RC, Triggianese P, Chimenti MS, Aboabat AA, Piga M, Monti S, Sebastiani GD, Yildirim D,
Conforti A, Gentileschi S, Dammacco R, Hinojosa-Azaola A, Kawakami-Campos PA, Ruffilli
F, Torres-Ruiz J, Thabet M, Atig A, Ruscitti P, Cataldi G, Viapiana O, Hatemi G, Karakoç A,
Costi S, Iagnocco A, Crisafulli F, Fragoulis G, Del Giudice E, Hegazy MT, Paroli MP, Şahin A,
Morrone M, Iannone F, Opris-Belinski D, Asfina KN, Barone P, Gaggiano C, Kucuk H,
Gicchino MF, Carubbi F, Caggiano V, Laskari K, Tharwat S, Direskeneli H, Alibaz-Oner F,
Sevik G, Maier A, Laymouna AH, Emmi G, Akkoç N, Tarsia M, Sbalchiero J, Conti G, Spinella
R, La Torre F, Tombetti E, Amin RH, Mauro A, Karamanakos A, Carreño E, Fonollosa A,
Cattalini M, Breda L, de-la-Torre A, Wiesik-Szewczyk E, Cifuentes-González C, Ozen S,
Mazzei MA, Tosi GM, Frediani B, Balistreri A, Batu ED, Gupta V, Cantarini L, Fabiani C. Ocul
Immunol Inflamm. 2024 May 17:1-8. doi: 10.1080/09273948.2024.2346815. Online
ahead of print. PMID: 38759215
102. Risk for cancer development in familial Mediterranean fever and associated
predisposing factors: an ambidirectional cohort study from the international AIDA
Network registries. Vitale A, Caggiano V, Tufan A, Ragab G, Batu ED, Portincasa P, Aragona
E, Sota J, Conti G, De Paulis A, Rigante D, Olivieri AN, Şahin A, La Torre F, Lopalco G, Cattalini
M, Maggio MC, Insalaco A, Sfikakis PP, Verrecchia E, Yildirim D, Kucuk H, Kardas RC,
Laymouna AH, Ghanema M, Saad MA, Sener S, Ercan Emreol H, Ozen S, Jaber N, Khalil M,
Di Ciaula A, Gaggiano C, Malizia G, Affronti A, Patroniti S, Romeo M, Sbalchiero J, Della
Casa F, Mormile I, Silvaroli S, Gicchino MF, Çelik NÇ, Tarsia M, Karamanakos A, HernándezRodríguez J, Parronchi P, Opris-Belinski D, Barone P, Recke A, Costi S, Sfriso P, Giardini HAM,
Gentileschi S, Wiesik-Szewczyk E, Vasi I, Loconte R, Jahnz-Różyk K, Martín-Nares E, TorresRuiz J, Cauli A, Conforti A, Emmi G, Li Gobbi F, Biasi GR, Terribili R, Ruscitti P, Del Giudice E,
Tharwat S, Brucato AL, Ogunjimi B, Hinojosa-Azaola A, Balistreri A, Fabiani C, Frediani B,
Cantarini L. Front Immunol. 2024 May 10; 15:1397890. Doi:
10.3389/fimmu.2024.1397890. eCollection 2024. PMID: 38799474
103. Moving Together, Apart: Impacts of Travel Restrictions on a UK-Egypt
Collaboration in Health Profession Education. Ragab L, Wassim M, Arfeen Z, Newman R,
Rashid MA. J Med Educ Curric Dev. 2024 May 9; 11:23821205241253668. Doi:
10.1177/23821205241253668. eCollection 2024 Jan-Dec. PMID: 38736713 Free PMC
article.
104. Occipital nerve stimulation in pediatric patients with refractory occipital
neuralgia. Mossner J, Saleh NB, Shahin MN, Rosenow JM, Raskin JS.Childs Nerv Syst. 2024
Aug;40(8):2465-2470. doi: 10.1007/s00381-024-06376-x. Epub 2024 Apr 2.PMID:
38563970 Free PMC article.
105. Optimized mucoadhesive niosomal carriers for intranasal delivery of carvedilol:
A quality by design approach. Azrak ZAT, Taha MS, Jagal J, Elsherbeny A, Bayraktutan H,
AbouGhaly MHH, Elshafeey AH, Greish K, Haider M. Int J Pharm. 2024 Apr 10;654:123935.
Doi: 10.1016/j.ijpharm.2024.123935. Epub 2024 Feb 21. PMID: 38395319
106. The association of FSCN1 (rs852479, rs1640233) and HOTAIR (rs920778)
polymorphisms with the risk of breast cancer in Egyptian women. Galal ER, Abdelhakam
DA, Ahmed LK, Elhusseny Y, Sayed SEP, Eltaweel NH. Mol Biol Rep. 2024 Apr 8;51(1):495.
Doi: 10.1007/s11033-024-09459-9. PMID: 38587571
107. NephroConnect: Patterns, Preferences, Barriers, and Potentials in the Global
Nephrology Community’s Social Media Landscape. Bek SG, Karam S, Murphy DP, MouraNeto JA, Balcı S, Gawad MA, Claure-Del Granado R, Parikh N, Gopal B, Yadla M, Tannor E,
Nlandu Y, Turgut D, Parada XV, Akl A, Soares Dos Santos Junior AC, Arce-Amare F, Anandh
U, Lerma E, Baharani J.Kidney Int Rep. 2024 Apr 4;9(6):1557-1560. doi:
10.1016/j.ekir.2024.04.009. eCollection 2024 Jun.PMID: 38899215 Free PMC article. No
abstract available.
108. Liver transplantation as an alternative for the treatment of intrahepatic
cholangiocarcinoma: Past, present, and future directions. Kodali S, Connor AA, Thabet S,
Brombosz EW, Ghobrial RM. Hepatobiliary Pancreat Dis Int. 2024 Apr;23(2):129-138.
Doi: 10.1016/j.hbpd.2023.07.007. Epub 2023 Jul 23. PMID: 37517983 Review.
109. Splicing Switching of Alternative Last Exons Due to a Deletion Including Canonical
Polyadenylation Site in COL6A2 Gene Causes Recessive UCMD. El Sherif, R., Saito, Y.,
Awaya, T., Noguchi, S., & Nishino, I., Neurology. Genetics, 2024 Mar 10(2), e200137.
https://doi.org/10.1212/NXG.0000000000200137
110. The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data
from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry.
Ruscitti P, Masedu F, Vitale A, Caggiano V, Di Cola I, Cipriani P, Valenti M, Mayrink Giardini
HA, de Brito Antonelli IP, Dagostin MA, Lopalco G, Iannone F, Maria M, Almaghlouth IA,
Asfina KN, Ali HH, Ciccia F, Iacono D, Pantano I, Mauro D, Sfikakis PP, Tektonidou M, Laskari
K, Berardicurti O, Dagna L, Tomelleri A, Tufan A, Can Kardas R, Hinojosa-Azaola A, MartínNares E, Kawakami-Campos PA, Ragab G, Hegazy MT, Direskeneli H, Alibaz-Oner F, Fotis L,
Sfriso P, Govoni M, La Torre F, Cristina Maggio M, Montecucco C, De Stefano L, Bugatti S,
Rossi S, Makowska J, Del Giudice E, Emmi G, Bartoloni E, Hernández-Rodríguez J, Conti G,
Nunzia Olivieri A, Gullo AL, Simonini G, Viapiana O, Wiesik-Szewczyk E, Erten S, Carubbi F,
De Paulis A, Maier A, Tharwat S, Costi S, Iagnocco A, Sebastiani GD, Gidaro A, Brucato AL,
Karamanakos A, Akkoç N, Caso F, Costa L, Prete M, Perosa F, Atzeni F, Guggino G, Fabiani
C, Frediani B, Giacomelli R, Cantarini L. Arthritis Rheumatology. 2024 Mar 18. Doi:
10.1002/art.42845. Online ahead of print. PMID: 38499989
111. Randomized, controlled pilot study of oral roflumilast compared to
intramuscular methotrexate for plaque and scalp psoriasis (DOI:
https://doi.org/10.1016/j.jaad.2024.01.018)
112. Recurrent papulonodular herpes zoster, with syringitis, folliculitis, and vasculitis
as clues to the diagnosis. Fawzy MM, El-Enany G, Abdelraouf SMA, Abdelkader HA. J Cutan
Pathol. 2024 Mar;51(3):205-208. Doi: 10.1111/cup.14566. Epub 2023 Dec 8. PMID:
38063075
113. Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: RealLife Data from the International AIDA Network Uveitis Registry. Tarsia M, Vitale A,
Gaggiano C, Sota J, Maselli A, Bellantonio C, Guerriero S, Dammacco R, La Torre F, Ragab
G, Hegazy MT, Fonollosa A, Paroli MP, Del Giudice E, Maggio MC, Cattalini M, Fotis L, Conti
G, Mauro A, Civino A, Diomeda F, de-la-Torre A, Cifuentes-González C, Tharwat S,
Hernández-Rodríguez J, Gómez-Caverzaschi V, Pelegrín L, Babu K, Gupta V, Minoia F,
Ruscitti P, Costi S, Breda L, La Bella S, Conforti A, Mazzei MA, Carreño E, Amin RH, Grosso
S, Frediani B, Tosi GM, Balistreri A, Cantarini L, Fabiani C. Ophthalmol Ther. 2024
Mar;13(3):761-774. doi: 10.1007/s40123-023-00863-1. Epub 2024 Jan 11. PMID:
38206518
114. CCN3, POSTN, and PTHLH as potential key regulators of genomic integrity and
cellular survival in iPSCs. Swaidan NT, Soliman NH, Aboughalia AT, Darwish T, Almeshal
RO, Al-Khulaifi AA, Taha RZ, Alanany R, Hussein AY, Salloum-Asfar S, Abdulla SA, Abdallah
AM, Emara MM. Front Mol Biosci. 2024 Feb 5; 11:1342011. Doi:
10.3389/fmolb.2024.1342011. eCollection 2024. PMID: 38375508
115. Invited Response on: Effectiveness and Role of Using Hyaluronic Acid Injections
for Gluteal Augmentation: A Comprehensive Systematic Review of Techniques and
Outcomes. Mortada H, Alkadi D, Saqr H. Aesthetic Plast Surg. 2024 Jan 9. Doi:
10.1007/s00266-023-03806-0. Online ahead of print. PMID: 38195899
116. Serum Copeptin as a Cardiomyopathy Predictor in Thalassemic Children:
Relation to Tei Index. Safwat NA , Youssef OI, Attia H, Kenny MA. 2024. The Egyptian
Journal of Hospital Medicine. Review
117. Single-center experience in home management of mild and moderate COVID-19
cases. Hegazy MT, Abdel-Hamid HM, Salem AA, Nagy F, Rizk SE, Abd El Wahab H, Naguib
I, El Assaly H, Farwaela HM, Morad MA, Mortagy M, Attia H, Elebrashy I, Mattar M, Ibrahim
MHE 2024. J Infect Dev Ctries. doi: 10.3855/jidc.19243.
118. Correction: Clinical and laboratory features associated with macrophage
activation syndrome in Still’s disease: data from the international AIDA Network Still’s
Disease Registry. Triggianese P, Vitale A, Lopalco G, Mayrink Giardini HA, Ciccia F, AlMaghlouth I, Ruscitti P, Sfikakis PP, Iannone F, de Brito Antonelli IP, Patrone M, Asfina KN,
Di Cola I, Laskari K, Gaggiano C, Tufan A, Sfriso P, Dagna L, Giacomelli R, Hinojosa-Azaola
A, Ragab G, Fotis L, Direskeneli H, Spedicato V, Dagostin MA, Iacono D, Ali HH, Cipriani P,
Sota J, Kardas RC, Bindoli S, Campochiaro C, Navarini L, Gentileschi S, Martín-Nares E,
Torres-Ruiz J, Saad MA, Kourtesi K, Alibaz-Oner F, Sevik G, Iagnocco A, Makowska J, Govoni
M, Monti S, Maggio MC, La Torre F, Del Giudice E, Hernández-Rodríguez J, Bartoloni E,
Emmi G, Chimenti MS, Maier A, Simonini G, Conti G, Olivieri AN, Tarsia M, De Paulis A, Lo
Gullo A, Więsik-Szewczyk E, Viapiana O, Ogunjimi B, Tharwat S, Erten S, Nuzzolese R,
Karamanakos A, Frassi M, Conforti A, Caggiano V, Marino A, Sebastiani GD, Gidaro A,
Tombetti E, Carubbi F, Rubegni G, Cartocci A, Balistreri A, Fabiani C, Frediani B, Cantarini
L. Intern Emerg Med. 2024 Jan;19(1):255-257. Doi: 10.1007/s11739-023-03511-5. PMID:
38151591
119. Epigenetic alterations of miR-155 and global DNA methylation as potential
mediators of ochratoxin A cytotoxicity and carcinogenicity in human lung fibroblasts.
Kharboush TG, Ahmed IA, Farag AA, Kharboush T, Sayed AEH, Abdel-Kareim AM, Al
Mohaini M, Attia H, Eid RA, Zaki MSA, Al-Tabbakh AM. Environ Sci Pollut Res Int. 2024
Jan;31(4):5473-5483. Doi: 10.1007/s11356-023-31283-0. Epub 2023 Dec 20. PMID:
38114706
120. Medical students’ satisfaction towards videos as flipped classroom materials.
Omar H, Zaki R, Hayek N, Mohsen L. Educ Health 2024 ;37:284-286. Online access:
www.educationforhealthjournal.org DOI: 10.62694/efh.2024.100.
121. Exosomes Extracted from Adipose Tissue Stem Cells Alleviate Rotenone-Induced
Nigrostriatal Neurodegeneration, Glial Cell Activation, Synucleinopathy and Motor
Incoordination via Modulation of Autophagy/MiRNA7/MiRNA21. 2024
https://doi.org/10.23812/j.biol.regul.homeost.agents.20233712.652
122. Preliminary Study of sCD14 and sCD163 as Predictors of Disease Severity and ICU
Admission in COVID-19: Relation to Hematological Parameters, Blood Morphological
Changes and Inflammatory Biomarkers. Attia H, El Nagdy M, Abdel Halim RM. Mediterr J
Hematol Infect Dis. 2023 Sep 1;15(1):e2023046. doi: 10.4084/MJHID.2023.046. PMID:
37705527; PMCID: PMC10497305.
123. Integrating AI and ML in Myelodysplastic Syndrome Diagnosis: State-of-the-Art
and Future Prospects. Elshoeibi AM, Badr A, Elsayed B, Metwally O, Elshoeibi R, Elhadary
MR, Elshoeibi A, Attya MA, Khadadah F, Alshurafa A, Alhuraiji A, Yassin M. Cancers (Basel).
2023 Dec 22;16(1):65. Doi: 10.3390/cancers16010065. PMID: 38201493 Free PMC article.
Review.
124. Twitter as educational tool: a global web-based cross-sectional study on social
media behavior of nephrologists. Sourabh Sharma, Elliot Koranteng Tannor, Reny Duarsa,
Shubharthi Kar, Mohammed Abdel Gawad, Krishna K. Agrawal, Yannick Mayamba Nlandu,
Carlos Mauel Orantes-Navarro, Neha Sharma, Urmila Anandh 2023, Kidney International
Reports, DOI: 10.1016/j.ekir.2023.08.009
125. Efficacy of canakinumab in patients with Still’s disease across different lines of
biologic therapy: real-life data from the International AIDA Network Registry for Still’s
Disease. Vitale A, Caggiano V, Sfikakis PP, Dagna L, Lopalco G, Ragab G, La Torre F,
Almaghlouth IA, Maggio MC, Sota J, Tufan A, Hinojosa-Azaola A, Iannone F, Loconte R,
Laskari K, Direskeneli H, Ruscitti P, Morrone M, Mayrink Giardini HA, Panagiotopoulos A,
Di Cola I, Martín-Nares E, Monti S, De Stefano L, Kardas RC, Duran R, Campochiaro C,
Tomelleri A, Alabdulkareem AM, Gaggiano C, Tarsia M, Bartoloni E, Romeo M, Hussein
MA, Laymouna AH, Parente de Brito Antonelli I, Dagostin MA, Fotis L, Bindoli S, Navarini
L, Alibaz-Oner F, Sevik G, Frassi M, Ciccia F, Iacono D, Crisafulli F, Portincasa P, Jaber N,
Kawakami-Campos PA, Wiesik-Szewczyk E, Iagnocco A, Simonini G, Sfriso P, Balistreri A,
Giacomelli R, Conti G, Frediani B, Fabiani C, Cantarini L. Front Med (Lausanne). 2023 Dec
12; 10:1256243. Doi: 10.3389/fmed.2023.1256243. eCollection 2023. PMID: 38148914
126. Still’s disease continuum from childhood to elderly: data from the international
AIDA Network Still’s disease registry. Vitale A, Caggiano V, Lopalco G, Mayrink Giardini
HA, Ciccia F, Almaghlouth IA, Ruscitti P, Sfikakis PP, Tufan A, Dagna L, Giacomelli R,
Hinojosa-Azaola A, Ragab G, Direskeneli H, Fotis L, Sota J, Iannone F, Morrone M, de Brito
Antonelli IP, Dagostin MA, Iacono D, Patrone M, Asfina K, Alanazi F, Di Cola I, Gaggiano C,
Tektonidou MG, Kardas RC, Kucuk H, Campochiaro C, Tomelleri A, Navarini L, Berardicurti
O, Martín-Nares E, Torres-Ruiz J, Mahmoud AAA, Alibaz-Oner F, Kourtesi K, Tarsia M, Sfriso
P, Makowska J, Govoni M, La Torre F, Maggio MC, Monti S, Del Giudice E, Emmi G, Bartoloni
E, Hernández-Rodríguez J, Gómez-Caverzaschi V, Maier A, Simonini G, Iagnocco A, Conti
G, Olivieri AN, De Paulis A, Lo Gullo A, Viapiana O, Wiesik-Szewczyk E, Erten S, Ogunjimi B,
Carubbi F, Tharwat S, Laskari K, Costi S, Triggianese P, Karamanakos A, Conforti A, Frassi
M, Sebastiani GD, Gidaro A, Mauro A, Balistreri A, Fabiani C, Frediani B, Cantarini L. RMD
Open. 2023 Dec 1;9(4): e003578. doi: 10.1136/rmdopen-2023-003578. PMID: 38053457
127. Early Cost-Utility Analysis of Ataluren and Eteplirsen in the Treatment of
Duchenne Muscular Dystrophy in Egypt. Shehata, Z., Metry, A., Rabea, H., El Sherif, R.,
Abdelrahim, M., & Dawoud, D. Value in regional health issues, 2023 Nov 38, 109–117.
https://doi.org/10.1016/j.vhri.2023.08.004
128. Effectiveness and Role of Using Hyaluronic Acid Injections for Gluteal
Augmentation: A Comprehensive Systematic Review of Techniques and Outcomes.
Mortada H, Alkadi D, Saqr H, Sultan F, Alturaiki B, Alrobaiea S, Aljaaly HA, Arab K, Arkoubi
AY. Aesthetic Plast Surg. 2023 Dec;47(6):2719-2733. doi: 10.1007/s00266-023-03458-0.
Epub 2023 Jul 5. PMID: 37407710 Review.
129. Detection of AZFc gene deletion in a cohort of Egyptian patients with idiopathic
male infertility. Eid MM, Eid OM, Abdelrahman AH, Abdelrahman IFS, Aboelkomsan EAF,
AbdelKader RMA, Hassan M, Farid M, Ibrahim AA, Abd El-Fattah SN, Mahrous R. J Genet
Eng Biotechnol. 2023 Nov 10;21(1):111. Doi: 10.1186/s43141-023-00584-9. PMID:
37947911
130. SGLT-2 inhibitors enhance the effect of metformin to ameliorate hormonal
changes and inflammatory markers in a rat PCOS model. Mahmoud MM, Rashed LA,
Soliman SA, Sayed SM, Kamel O, Kamar SS, Hussien RES. Physiol Rep. 2023 Nov;11(22):
e15858. Doi: 10.14814/phy2.15858. PMID: 37985173 Free PMC article.
131. Early Cost-Utility Analysis of Ataluren and Eteplirsen in the Treatment of
Duchenne Muscular Dystrophy in Egypt. Shehata Z, Metry A, Rabea H, El Sherif R,
Abdelrahim M, Dawoud D. Value Health Reg Issues. 2023 Nov; 38:109-117. Doi:
10.1016/j.vhri.2023.08.004. Epub 2023 Oct 18. PMID: 37862859
132. 1. Acral Speckled Hypomelanosis: A Case Report and a Review of Literature 2023
(DOI: 10.1097/DAD.0000000000002437)
133. Derivation and validation of four patient clusters in Still’s disease, results from
GIRRCS AOSD-study group and AIDA Network Still Disease Registry. Ruscitti P, Masedu F,
Vitale A, Di Cola I, Caggiano V, Di Muzio C, Cipriani P, Valenti M, Berardicurti O, Navarini L,
Iacono D, Pantano I, Mauro D, Ciccia F, Rossi S, De Stefano L, Monti S, Bugatti S,
Montecucco C, Caso F, Costa L, Prete M, Perosa F, Iagnocco A, Atzeni F, Guggino G, Giardini
H, Antonelli IPB, Almaghlouth IA, Asfina K, Direskeneli H, Alibaz-Oner F, Sevik G, Tufan A,
Sfikakis PP, La Torre F, Hinojosa-Azaola A, Martín-Nares E, Torres-Ruiz J, Ragab G, Maggio
MC, Makowska J, Del Giudice E, Bartoloni E, Emmi G, Govoni M, Lo Gullo A, Lopalco G,
Simonini G, Fotis L, Ogunjimi B, Tharwat S, Frediani B, Maier A, Carubbi F, Dagna L, Erten
S, Gidaro A, Hernández-Rodríguez J, Sfriso P, Fabiani C, Giacomelli R, Cantarini L. RMD
Open. 2023 Nov;9(4): e003419. doi: 10.1136/rmdopen-2023-003419. PMID: 37989322
134. Clinical and laboratory features associated with macrophage activation
syndrome in Still’s disease: data from the international AIDA Network Still’s Disease
Registry. Triggianese P, Vitale A, Lopalco G, Mayrink Giardini HA, Ciccia F, Al-Maghlouth I,
Ruscitti P, Sfikakis PP, Iannone F, de Brito Antonelli IP, Patrone M, Asfina KN, Di Cola I,
Laskari K, Gaggiano C, Tufan A, Sfriso P, Dagna L, Giacomelli R, Hinojosa-Azaola A, Ragab
G, Fotis L, Direskeneli H, Spedicato V, Dagostin MA, Iacono D, Ali HH, Cipriani P, Sota J,
Kardas RC, Bindoli S, Campochiaro C, Navarini L, Gentileschi S, Martín-Nares E, Torres-Ruiz
J, Saad MA, Kourtesi K, Alibaz-Oner F, Sevik G, Iagnocco A, Makowska J, Govoni M, Monti
S, Maggio MC, La Torre F, Del Giudice E, Hernández-Rodríguez J, Bartoloni E, Emmi G,
Chimenti MS, Maier A, Simonini G, Conti G, Olivieri AN, Tarsia M, De Paulis A, Lo Gullo A,
Więsik-Szewczyk E, Viapiana O, Ogunjimi B, Tharwat S, Erten S, Nuzzolese R, Karamanakos
A, Frassi M, Conforti A, Caggiano V, Marino A, Sebastiani GD, Gidaro A, Tombetti E, Carubbi
F, Rubegni G, Cartocci A, Balistreri A, Fabiani C, Frediani B, Cantarini L. Intern Emerg Med.
2023 Nov;18(8):2231-2243. doi: 10.1007/s11739-023-03408-3. Epub 2023 Oct 12. PMID:
37828268 Free PMC article.
135. Revolutionizing chronic lymphocytic leukemia diagnosis: A deep dive into the
diverse applications of machine learning. Elhadary M, Elshoeibi AM, Badr A, Elsayed B,
Metwally O, Elshoeibi AM, Mattar M, Alfarsi K, AlShammari S, Alshurafa A, Yassin M. Blood
Rev. 2023 Nov;62:101134. doi: 10.1016/j.blre.2023.101134. Epub 2023 Sep 22. PMID:
37758527 Review.
136. The administration of methotrexate in patients with Still’s disease, “real-life”
findings from AIDA Network Still Disease Registry. Ruscitti P, Sota J, Vitale A, Lopalco G,
Iannone F, Morrone M, Giardini HAM, D’Agostin MA, Antonelli IPB, Almaghlouth I, Asfina
KN, Khalil N, Sfikakis PP, Laskari K, Tektonidou M, Ciccia F, Iacono D, Riccio F, Ragab G,
Hussein MA, Govoni M, Ruffilli F, Direskeneli H, Alibaz-Oner F, Giacomelli R, Navarini L,
Bartoloni E, Riccucci I, Martín-Nares E, Torres-Ruiz J, Cipriani P, Di Cola I, HernándezRodríguez J, Gómez-Caverzaschi V, Dagna L, Tomelleri A, Makowska J, Brzezinska O,
Iagnocco A, Bellis E, Caggiano V, Gaggiano C, Tarsia M, Mormile I, Emmi G, Sfriso P, Monti
S, Erten Ş, Del Giudice E, Lubrano R, Conti G, Olivieri AN, Lo Gullo A, Tharwat S,
Karamanakos A, Gidaro A, Maggio MC, La Torre F, Cardinale F, Ogunjimi B, Maier A,
Sebastiani GD, Opris-Belinski D, Frassi M, Viapiana O, Bizzi E, Carubbi F, Fotis L, Tufan A,
Kardas RC, Więsik-Szewczyk E, Jahnz-Różyk K, Fabiani C, Frediani B, Balistreri A, Rigante D,
Cantarini L. Semin Arthritis Rheum. 2023 Oct; 62:152244. Doi:
10.1016/j.semarthrit.2023.152244. Epub 2023 Jul 21. PMID: 37517110
137. Melatonin Alleviates Intestinal Barrier Damaging Effects Induced by
Polyethylene Microplastics in Albino Rats. El Gazzar WB, Sliem RE, Bayoumi H, Nasr HE,
Shabanah M, Elalfy A, Radwaan SE, Gebba MA, Mansour HM, Badr AM, Amer MF, Ashour
SS, Morsi H, Aboelkomsan ESAF, Baioumy B, Sayed AEH, Farag AA. Int J Mol Sci. 2023 Sep
3;24(17):13619. Doi: 10.3390/ijms241713619. PMID: 37686424
138. Letter to the Editor Regarding “Outcomes of Intramuscular Gluteal
Augmentation with Implants Using Tumescent Local Anesthesia”. Saqr H, El Fahar MH.
Aesthetic Plast Surg. 2023 Aug 28. doi: 10.1007/s00266-023-03585-8. Online ahead of
print. PMID: 37639025
139. Using the Health Belief Model to assess COVID-19 perceptions and behaviours
among a group of Egyptian adults: a cross-sectional study. Boulos DNK, Hassan AM. BMC
Public Health. 2023 Aug 25;23(1):1624. doi: 10.1186/s12889-023-16513-x. PMID:
37626356 Free PMC article.
140. Autoinflammatory diseases and the kidney. Hegazy MT, Fayed A, Nuzzolese R,
Sota J, Ragab G. Immunol Res. 2023 Aug;71(4):578-587. Doi: 10.1007/s12026-023-09375-
3. Epub 2023 Mar 29. PMID: 36991303. Review.
141. Twitter as Educational Tool: A Global Web-Based Cross-Sectional Study on Social
Media Behavior of Nephrologists. Sharma S, Tannor EK, Duarsa R, Kar S, Gawad MA,
Agrawal KK, Nlandu YM, Orantes-Navarro CM, Sharma N, Anandh U. Kidney Int Rep. 2023
Aug 19;8(11):2469-2473. Doi: 10.1016/j.ekir.2023.08.009. eCollection 2023 Nov. PMID:
38025224
142. Vitamin D level in ankylosing spondylitis male patients: A potential association
with the functional status and platelet count. Al-Naggar, E. M., El-Sawy, S. S., Abdo, D.
M., Attia, D. H., & ElSawy, W. S. The Egyptian Rheumatologist. 2023, July 19;45(4), 289-
293. https://doi.org/10.1016/j.ejr.2023.07.001
143. Evolution of Superficial Muscular Aponeurotic System Facelift Techniques: A
Comprehensive Systematic Review of Complications and Outcomes. Mortada H, Alkilani
N, Halawani IR, Zaid WA, Alkahtani RS, Saqr H, Neel OF. JPRAS Open. 2023 Jun 8; 39:166-
180. Doi: 10.1016/j.jpra.2023.06.003. eCollection 2024 Mar. PMID: 38283861 Review.
144. Causes of death among patients with cutaneous melanoma: a US populationbased study. Sadeq MA, Ashry MH, Ghorab RMF, Afify AY. Sci Rep. 2023 Jun
24;13(1):10257. doi: 10.1038/s41598-023-37333-4. PMID: 37355743
145. A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project.
Gaggiano C, Del Bianco A, Sota J, Gentileschi S, Ruscitti P, Giacomelli R, Piga M, Crisafulli F,
Monti S, Emmi G, De Paulis A, Vitale A, Tarsia M, Caggiano V, Nuzzolese R, Parretti V,
Fabiani C, Lopalco G, Maier A, Cattalini M, Rigante D, Govoni M, Li Gobbi F, Guiducci S,
Parronchi P, Marino A, Ciccia F, Maggio MC, Aragona E, Bartoloni E, Iagnocco A, Viapiana
O, Sebastiani GD, Guerriero S, Insalaco A, Del Giudice E, Conti G, Barone P, Olivieri AN,
Brucato A, Carubbi F, Triggianese P, Mauro A, Tosi GM, Fonollosa A, Giardini HAM, Ragab
G, Tharwat S, Hernández-Rodríguez J, Sfikakis PP, Laskari K, Karamanakos A, Espinosa G,
Shahram F, Direskeneli H, Hinojosa-Azaola A, Opris-Belinski D, AlMaghlouth IA, Hatemi G,
Eksin MA, Önen F, Więsik-Szewczyk E, Akkoç N, Tufan A, Şahin A, Erten Ş, Ozen S, Batu ED,
Frediani B, Balistreri A, Cantarini L. Front Med (Lausanne). 2023 Jun 16; 10:1188021. doi:
10.3389/fmed.2023.1188021. eCollection 2023. PMID: 37396916
146. Axial spondyloarthritis in patients with recurrent fever attacks: data from the
AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs). Vitale
A, Caggiano V, Silva I, Oliveira DG, Ruscitti P, Ciccia F, Vasi I, Tufan A, Lopalco G,
AlMaghlouth IA, Sota J, Wiesik-Szewczyk E, Gaggiano C, Giardini HAM, Spedicato V, Ragab
G, Iannone F, Balistreri A, Frassi M, Hernández-Rodríguez J, Fabiani C, Falsetti P, Di Meglio
N, Frediani B, Mazzei MA, Rigante D, Faria R, Cantarini L. Front Med (Lausanne). 2023 May
30; 10:1195995. doi: 10.3389/fmed.2023.1195995. eCollection 2023. PMID: 37324154.
147. Kasr Alainy simplified uterine preserving surgery for conservative management
of placenta accreta spectrum (PAS): A modified surgical approach. Mousa A, Elkhateb IT,
Gaafar HM, Elsherbini MM, Mousa H, Abdalla M, Abdelbar A, Rida D, Majd HS, Collins SL.
Eur J Obstet Gynecol Reprod Biol. 2023 May;284:150-161. Doi:
10.1016/j.ejogrb.2023.03.026. Epub 2023 Mar 24. PMID: 37001252
148. Causes of death after laryngeal cancer diagnosis: A US population-based study.
Afify AY, Ashry MH, Sadeq MA, Elsaid M. Eur Arch Otorhinolaryngol. 2023
Apr;280(4):1855-1864. doi: 10.1007/s00405-022-07730-y. Epub 2022 Nov 10. PMID:
36357608
149. The precision of two alternative indirect workflows for digital model production:
an illusion or a possibility? Elkersh NM, Fahmy RA, Zayet MK, Gaweesh YS, Hassan MG.
Clin Oral Investig. 2023 Jul;27(7):3787-3797. Doi: 10.1007/s00784-023-04996-2. Epub
2023 Apr 13 PMID: 37046002
150. Causes of death after laryngeal cancer diagnosis: A US population-based study.
Afify AY, Ashry MH, Sadeq MA, Elsaid M. Eur Arch Otorhinolaryngol. 2023
Apr;280(4):1855-1864. doi: 10.1007/s00405-022-07730-y. Epub 2022 Nov 10. PMID:
36357608
151. Musculoskeletal manifestations in children with Behçet’s syndrome: data from
the AIDA Network Behçet’s Syndrome Registry. Gaggiano C, Maselli A, Sfikakis PP, Laskari
K, Ragab G, Hegazy MT, Laymouna AH, Lopalco G, Almaghlouth IA, Asfina KN, Alahmed O,
Giardini Mayrink HA, Parente de Brito Antonelli I, Cattalini M, Piga M, Sota J, Gentileschi
S, Maggio MC, Opris-Belinski D, Hatemi G, Insalaco A, Olivieri AN, Tufan A, Karadeniz H,
Kardaş RC, La Torre F, Cardinale F, Marino A, Guerriero S, Ruscitti P, Tarsia M, Vitale A,
Caggiano V, Telesca S, Iannone F, Parretti V, Frassi M, Aragona E, Ciccia F, Wiesik-Szewczyk
E, Ionescu R, Şahin A, Akkoç N, Hinojosa-Azaola A, Tharwat S, Hernández-Rodríguez J,
Espinosa G, Conti G, Del Giudice E, Govoni M, Emmi G, Fabiani C, Balistreri A, Frediani B,
Rigante D, Cantarini L; AIDA Network. Intern Emerg Med. 2023 Apr;18(3):743-754. doi:
10.1007/s11739-023-03215-w. Epub 2023 Mar 7. PMID: 36881285. Clinical Trial.
152. MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel
therapeutic tool against hepatocellular carcinoma. Hassan M, Elzallat M, Aboushousha T,
Elhusseny Y, El-Ahwany E. Noncoding RNA Res. 2022 Nov 23;8(1):126-134. doi:
10.1016/j.ncrna.2022.11.005. eCollection 2023 Mar. PMID: 36474748 Free PMC article.
153. Estimating Societal Cost of Illness and Patients’ Quality of Life of Duchenne
Muscular Dystrophy in Egypt. Shehata ZH, Rabea H, El Sherif R, Abdelrahim ME, Dawoud
DM. Value Health Reg Issues. 2023, Jan; 33:10-16.
https://doi.org/10.1016/j.vhri.2022.08.006
154. Incidence trends of gastric cancer among adolescents and young adults. Afify AY.
J Gastroenterol Hepatol. 2023 Feb;38(2):337. Doi: 10.1111/jgh.16095. Epub 2023 Jan 4.
PMID: 36575947
155. Combination of acitretin and narrowband UV-B for the treatment of vitiligo: A
new treatment modality with an impact on tissue E-cadherin expression. Ramadan S,
Zeid OA, Esmat S, Saleh NA, Assaf M, Hilal RF. J Am Acad Dermatol. 2023 Jan;88(1):241-
243. doi: 10.1016/j.jaad.2022.05.012. Epub 2022 May 13. PMID: 35569592
156. Estimating Societal Cost of Illness and Patients’ Quality of Life of Duchenne
Muscular Dystrophy in Egypt. Shehata ZH, Rabea H, El Sherif R, Abdelrahim ME, Dawoud
DM. Value Health Reg Issues. 2023 Jan; 33:10-16. doi: 10.1016/j.vhri.2022.08.006. Epub
2022 Sep 23. PMID: 36162195
157. Characteristics of TP53 mutation in adult precursor B-cell acute lymphoblastic
leukemia. Samy H, Fouad DA and Attia H. 2023 Egyptian journal of haematology
DOI: 10.4103/ejh.ejh_92_22 Review
158. The study of the impact of additional chromosomal aberrations and c-MYC and
BCR::ABL1 genes amplification on CML patient’s characteristics: relation to
haematological parameters and patient outcome. Attia, H., Fouad, D.A. & Samy, H. 2023
Egypt J Med Hum Genetics https://doi.org/10.1186/s43042-023-00460-8 Review
159. Pigmented colloid miliumin a beta thalassemia major
patient: A Case report 2023 (doi:10.1111/ijd.16819)
160. Canakinumab as first-line biological therapy in Still’s disease and differences
between the systemic and the chronic-articular courses: Real-life experience from the
international AIDA registry. Vitale A, Caggiano V, Maggio MC, Lopalco G, Emmi G, Sota J,
La Torre F, Ruscitti P, Bartoloni E, Conti G, Fabiani C, Mattioli I, Gaggiano C, Cardinale F,
Dagna L, Campochiaro C, Giacomelli R, Balistreri A, Laskari K, Tufan A, Ragab G,
Almaghlouth IA, Więsik-Szewczyk E, Pereira RM, Frediani B, Iannone F, Sfikakis PP,
Cantarini L. Front Med (Lausanne). 2022 Dec 22; 9:1071732. doi:
10.3389/fmed.2022.1071732. eCollection 2022. PMID: 36619631.
161. Extensive cutaneous leukocytoclastic vasculitis after Sinopharm vaccine: Case
report and review of the literature 2022 (DOI:10.1111/cup.14235)
162. An approach to diagnosis of paraproteinemia. In Paraproteinemia and related
disorder Hegazy MT, Mahmoud AA, Attia H, and Ragab G. Textbook. Ragab G, Quartuccio
L, Goubran H. Introductory Chapter; P79. © The Editor(s) and The Author(s), under
exclusive license to Springer Nature Switzerland AG 2022. G. Ragab et al. (eds.),
Paraproteinemia and Related Disorders, https://doi.org/10.1007/978-3-031-10131-1
163. Evaluation of polypharmacy among chronic kidney disease patients in Egypt: A
cross-sectional study. Mohammed Abdel Gawad, Basma Abdulsamad, Rana Hanafy,
Noura Yousri, 2022, International Journal of Clinical Pharmacology and Therapeutics, DOI:
10.5414/cp204249
164. Online medical education in Egypt during the COVID-19 pandemic: a nationwide
assessment of medical students’ usage and perceptions. Mohamed Mortagy, Aya
Abdelhameed, Patricia Sexton, Melissa Olken, Mohamed Tharwat Hegazy, Mohammed
Abdel Gawad, Fathy Senna, Islam A. Mahmoud, Jaffer Shah, Egyptian Medical Education
Collaborative Group (EGY MedEd) & Hani Aiash, 2022, BMC medical education, DOI:
10.1186/s12909-022-03249-2
165. Egyptian renal data system (ERDS) 2020: an annual report of end-stage kidney
disease patients on regular hemodialysis. Hassaballa, May; El-Wakil, Hala; Elsharkawy,
Magdy; Khamis, Said; El Tantawy, Tarek; Wahby, Wael; Salem, Karem; Gawad, Mohammed
Abdel, 2022, Journal of The Egyptian Society of Nephrology and Transplantation, DOI:
10.4103/jesnt.jesnt_37_21
166. Blood transfusion in autoimmune rheumatic diseases. Goubran H, Ragab G,
Seghatchian J, Burnouf T. Transfus Apher Sci. 2022 Dec;61(6):103596. doi:
10.1016/j.transci.2022.103596. Epub 2022 Oct 28. PMID: 36371394
167. Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19,
FOXD2-AS1, and SNHG3 in HCC. Habashy DA, Hamad MHM, Ragheb M, Khalil ZA, El Sobky
SA, Hosny KA, Esmat G, El-Ekiaby N, Fawzy IO, Abdelaziz AI. Life Sci. 2022 Dec 1;
310:121075. Doi: 10.1016/j.lfs.2022.121075. Epub 2022 Oct 13. PMID: 36243115
168. Regulation of lipid droplet (LD) formation in hepatocytes via regulation of
SREBP1c by non-coding RNAs. El Sobky SA, Aboud NK, El Assaly NM, Fawzy IO, El-Ekiaby
N, Abdelaziz AI. Front Med (Lausanne). 2022 Sep 20; 9:903856. Doi:
10.3389/fmed.2022.903856. eCollection 2022. PMID: 36203751 Free PMC article.
169. Efficacy and safety of tocilizumab in adult-onset Still’s disease: Real-life
experience from the international AIDA registry. Sota J, Vitale A, Lopalco G, Pereira RMR,
Giordano HF, Antonelli IPB, Makowska J, Brzezińska O, Lewandowska-Polak A, Ruscitti P,
Cipriani P, Cola ID, Govoni M, Ruffili F, Sfikakis PP, Laskari K, Ragab G, Hussein MA,
Gentileschi S, Gaggiano C, La Torre F, Maier A, Emmi G, Marino A, Ciccia F, Sfriso P, Maggio
MC, Bartoloni E, Lomater C, Hegazy MT, Tektonidou M, Dagostin MA, Opinc A, Sebastiani
GD, Giacomelli R, Giudice ED, Olivieri AN, Tufan A, Kardas RK, Nuzzolese R, Cardinale F,
Więsik-Szewczyk E, Veronica P, Tarsia M, Iannone F, Della Casa F, Fabiani C, Frediani B,
Balistreri A, Rigante D, Cantarini L. Semin Arthritis Rheum. 2022 Dec; 57:152089. Doi:
10.1016/j.semarthrit.2022.152089. Epub 2022 Aug 30. PMID: 36063578
170. SARS-CoV-2 and cancer: the intriguing and informative cross-talk. Goubran H,
Stakiw J, Seghatchian J, Ragab G, Burnouf T. Transfus Apher Sci. 2022 Aug;61(4):103488.
Doi: 10.1016/j.transci.2022.103488. Epub 2022 Jun 14. PMID: 35753906 Free PMC article.
171. Evaluation of needling/microneedling as an adjunct to phototherapy in the
treatment of stable acral vitiligo: a comparative clinical and immunohistochemical
study. Esmat S, Assaf MI, Mohye Eldeen R, Gawdat HI, Saadi DG. J Dermatolog Treat. 2022
Aug;33(5):2621-2628. Doi: 10.1080/09546634.2022.2062279. Epub 2022 Apr 8. PMID:
35373693 Clinical Trial.
172. The Effect of Vitamin D And Swimming Exercise on The Reproductive System in
High Fat-Fed Adult Male Rats : NeuroQuantology. Safaa M. Sharrah et al. / August 2022
| Volume 20 | Issue 8 | Page 5690: 5698| doi: 10.14704/nq.2022.20.8.NQ44596
173. Development and implementation of the AIDA International Registry for
patients with Behçet’s disease. Vitale A, Della Casa F, Ragab G, Almaghlouth IA, Lopalco
G, Pereira RM, Guerriero S, Govoni M, Sfikakis PP, Giacomelli R, Ciccia F, Monti S, Ruscitti
P, Piga M, Lomater C, Tufan A, Opris-Belinski D, Emmi G, Hernández-Rodríguez J, Şahin A,
Sebastiani GD, Bartoloni E, Akkoç N, Gündüz ÖS, Cattalini M, Conti G, Hatemi G, Maier A,
Parronchi P, Del Giudice E, Erten S, Insalaco A, Li Gobbi F, Maggio MC, Shahram F, Caggiano
V, Hegazy MT, Asfina KN, Morrone M, Prado LL, Dammacco R, Ruffilli F, Arida A, Navarini
L, Pantano I, Cavagna L, Conforti A, Cauli A, Marucco EM, Kucuk H, Ionescu R, Mattioli I,
Espinosa G, Araújo O, Karkaş B, Canofari C, Sota J, Laymouna AH, Bedaiwi AA, Colella S,
Giardini HAM, Albano V, Lo Monaco A, Fragoulis GE, Kardas RC, Berlengiero V, Hussein
MA, Ricci F, La Torre F, Rigante D, Więsik-Szewczyk E, Frassi M, Gentileschi S, Tosi GM,
Dagostin MA, Mahmoud AAA, Tarsia M, Alessio G, Cimaz R, Giani T, Gaggiano C, Iannone
F, Cipriani P, Mourabi M, Spedicato V, Barneschi S, Aragona E, Balistreri A, Frediani B,
Fabiani C, Cantarini L; Autoinflammatory Diseases Alliance (AIDA) Network. Intern Emerg
Med. 2022 Oct;17(7):1977-1986. Doi: 10.1007/s11739-022-03038-1. Epub 2022 Jul 14.
PMID: 35831701
174. Development and Implementation of the AIDA International Registry for
Patients with VEXAS Syndrome. Vitale A, Caggiano V, Della Casa F, Hernández-Rodríguez
J, Frassi M, Monti S, Tufan A, Telesca S, Conticini E, Ragab G, Lopalco G, Almaghlouth I,
Pereira RMR, Yildirim D, Cattalini M, Marino A, Giani T, La Torre F, Ruscitti P, Aragona E,
Wiesik-Szewczyk E, Del Giudice E, Sfikakis PP, Govoni M, Emmi G, Maggio MC, Giacomelli
R, Ciccia F, Conti G, Ait-Idir D, Lomater C, Sabato V, Piga M, Sahin A, Opris-Belinski D,
Ionescu R, Bartoloni E, Franceschini F, Parronchi P, de Paulis A, Espinosa G, Maier A,
Sebastiani GD, Insalaco A, Shahram F, Sfriso P, Minoia F, Alessio M, Makowska J, Hatemi G,
Akkoç N, Li Gobbi F, Gidaro A, Olivieri AN, Al-Mayouf SM, Erten S, Gentileschi S, Vasi I,
Tarsia M, Mahmoud AAA, Frediani B, Fares Alzahrani M, Laymouna AH, Ricci F, Cardinale
F, Jahnz-Rózyk K, Tosi GM, Crisafulli F, Balistreri A, Dagostin MA, Ghanema M, Gaggiano C,
Sota J, Di Cola I, Fabiani C, Giardini HAM, Renieri A, Fabbiani A, Carrer A, Bocchia M, Caroni
F, Rigante D, Cantarini L. Front Med (Lausanne). 2022 Jul 11; 9:926500. Doi:
10.3389/fmed.2022.926500. eCollection 2022. PMID: 35899212.
175. Platelet and extracellular vesicles in COVID-19 infection and its vaccines.
Goubran H, Seghatchian J, Sabry W, Ragab G, Burnouf T. Transfus Apher Sci. 2022
Jun;61(3):103459. Doi: 10.1016/j.transci.2022.103459. Epub 2022 May 21. PMID:
35654711 Free PMC article. Review.
176. Evaluation of the ex-vivo porcine simulator on EUS-guided cystogastrostomy
using lumen-apposing metal stent training. Ibrahim M, Roshdy N, Taleb A, Alfadda A, AlLehibi A, Altonbary A, Galal A, El-Fouly A, Kozlowska A, Khor C, Isayama H, Okasha H,
Barthet M, Giovannini M, Pausawasdi N, Eisendrath P, Kongkam P, Ratanachu-Ek T, Nakai
Y. Endosc Ultrasound. 2022 May-Jun;11(3):201-207. doi: 10.4103/EUS-D-21-00109. PMID:
35708369
177. Development and Implementation of the AIDA International Registry for
Patients With Still’s Disease. Vitale A, Della Casa F, Lopalco G, Pereira RM, Ruscitti P,
Giacomelli R, Ragab G, La Torre F, Bartoloni E, Del Giudice E, Lomater C, Emmi G, Govoni
M, Maggio MC, Maier A, Makowska J, Ogunjimi B, Sfikakis PP, Sfriso P, Gaggiano C, Iannone
F, Dagostin MA, Di Cola I, Navarini L, Ahmed Mahmoud AA, Cardinale F, Riccucci I, Paroli
MP, Marucco EM, Mattioli I, Sota J, Abbruzzese A, Antonelli IPB, Cipriani P, Tufan A, Fabiani
C, Ramadan MM, Cattalini M, Kardas RC, Sebastiani GD, Giardini HAM, HernándezRodríguez J, Mastrorilli V, Więsik-Szewczyk E, Frassi M, Caggiano V, Telesca S, Giordano HF,
Guadalupi E, Giani T, Renieri A, Colella S, Cataldi G, Gentile M, Fabbiani A, Al-Maghlouth
IA, Frediani B, Balistreri A, Rigante D, Cantarini L. Front Med (Lausanne). 2022 Apr 7;
9:878797. Doi: 10.3389/fmed.2022.878797. eCollection 2022. PMID: 35463015 Free PMC
article.
178. Development and Implementation of the AIDA International Registry for
Patients with Non-Infectious Uveitis. Casa FD, Vitale A, Guerriero S, Sota J, Cimaz R, Ragab
G, Ruscitti P, Pereira RMR, Minoia F, Del Giudice E, Emmi G, Lomater C, Monti S, Canofari
C, Gaggiano C, Alessio G, Miserocchi E, Conforti A, Dagostin MA, Mapelli C, Paroli MP,
Parretti V, Albano V, Favale R, Marelli L, Hegazy MT, Cipriani P, Antonelli IPB, Caggiano V,
Aragona E, Laymouna AH, Tosi GM, Tarsia M, Cattalini M, La Torre F, Lopalco G, WięsikSzewczyk E, Frassi M, Gentileschi S, Giordano HF, Frediani B, Shinjo SK, Rigante D, Sfikakis
PP, Balistreri A, Hussein MA, Amin RH, Cantarini L, Fabiani C; Autoinflammatory Diseases
Alliance (AIDA) Network. Ophthalmol Ther. 2022 Apr;11(2):899-911. Doi:
10.1007/s40123-022-00459-1. Epub 2022 Jan 31. PMID: 35099782
179. Chronic Atrophic Scar-like Plaque: Challenge 2022
(DOI:10.1097/DAD.0000000000001996)
180. Chronic Atrophic Scar-Like Plaque: Answer 2022
(DOI:10.1097/DAD.0000000000001997)
181. Multiple Plantar Swellings as the Presenting Sign of a Systemic Disease:
Challenge. 2022 (DOI:10.1097/DAD.0000000000002112)
182. Multiple Plantar Swellings as the Presenting Sign of a Systemic Disease:
Answer. 2022 (DOI:10.1097/DAD.0000000000002111)
183. Frailty and Suicidality in Older Adults: A Mini-Review and Synthesis. Shah J,
Kandil OA, Mortagy M, Abdelhameed A, Shah A, Kuron M, Abdellatif YO. Gerontology.
2022;68(5):571-577. doi: 10.1159/000523789. Epub 2022 Apr 13. PMID: 35417914
184. Online medical education in Egypt during the COVID-19 pandemic: a nationwide
assessment of medical students’ usage and perceptions. Mortagy M, Abdelhameed A,
Sexton P, Olken M, Hegazy MT, Gawad MA, Senna F, Mahmoud IA, Shah J; Egyptian Medical
Education Collaborative Group (EGY MedEd); Aiash H. BMC Med Educ. 2022 Mar
30;22(1):218. doi: 10.1186/s12909-022-03249-2. PMID: 35354406 Free PMC article.
Review.
185. Challenges and Opportunities of a Virtual Nephrology Meeting: The ISN World
Congress of Nephrology 2021. Claure-Del Granado R, Anandh U, Lerma E, Conjeevaram
A, Arce-Amaré F, Dos Santos ACS Jr, Basu G, Bek S, Dhakal AK, Gawad MA, AkL A, Turgut D,
Karam S, Bajpai D, Pecoits-Filho R, Parikh N. Kidney Int Rep. 2022 Feb;7(2):133-137. Doi:
10.1016/j.ekir.2021.11.039. Epub 2021 Dec 8. PMID: 35036661
186. Hepatocellular carcinoma cell line-microenvironment induced cancer-associated
phenotype, genotype, and functionality in mesenchymal stem cells. Salah RA, Nasr MA,
El-Derby AM, Abd Elkodous M, Mohamed RH, El-Ekiaby N, Osama A, Elshenawy SE, Hamad
MHM, Magdeldin S, Gabr MM, Abdelaziz AI, El-Badri NS. Life Sci. 2022 Jan 1; 288:120168.
Doi: 10.1016/j.lfs.2021.120168. Epub 2021 Nov 23. PMID: 34826437
187. Breaking Borders: How Barriers to Global Mobility Hinder International
Partnerships in Academic Medicine. Wondimagegn D, Ragab L, Yifter H, Wassim M,
Rashid MA, Whitehead CR, Gill D, Soklaridis S. Acad Med. 2022 Jan 1;97(1):37-40. Doi:
10.1097/ACM.0000000000004257. PMID: 34323859 Free PMC article.
188. Diagnostic accuracy of hysterosalpingo-lidocaine-foam sonography combined
with power Doppler (HyLiFoSy-PD) compared to laparoscopy and dye testing in tubal
patency assessment in cases of infertility. Sharaf MF, Fawzy I, Elkhateb IT, Elmahgoub Y,
Idris O, Aboulghar M. Middle East Fertility Society Journal. 2022 Dec;27(1):1-
9.https://link.springer.com/article/10.1186/s43043-022-00125-3
189. The Role of Mesenchymal Stem Cells with Ascorbic Acid and NAcetylcysteine on
TNF-α, IL 1β, and NF-κβ Expressions in Acute Pancreatitis in Albino Rats.
https://doi.org/10.1155/2021/6229460
190. The curious case of miR-155 in SLE. Ibrahim SA, Afify AY, Fawzy IO, El-Ekiaby N,
Abdelaziz AI. Expert Rev Mol Med. 2021 Sep 1;23: e11. Doi: 10.1017/erm.2021.11. PMID:
34470679 Review.
191. The Role of Mesenchymal Stem Cells with Ascorbic Acid and N-Acetylcysteine on
TNF-α, IL 1β, and NF-κβ Expressions in Acute Pancreatitis in Albino Rats D Abdelhafez, E
Aboelkomsan, A El Sadik, N Lasheen, S Ashur, A Elshimy, GNB Morcos Journal of Diabetes
Research, 2021 – Wiley Online Library
192. Challenges and Opportunities of a Virtual Nephrology Meeting: The ISN World
Congress of Nephrology 2021, Rolando Claure-Del Granad, Urmila Anandh, Edgar Lerma,
Arvind Conjeevaram, Fernanda Arce-Amaré, Augusto Cesar Soares Dos Santos Jr, Gopal
Basu, Sibel Bek, Ajaya Kumar Dhakal, Mohammed Abdel Gawad, Ahmed AkL, Didem
Turgut, Sabine Karam, Divya Bajpai, Roberto Pecoits-Filho, Namrata Parikh, 2021, Kidney
International Reports, DOI: 10.1016/j.ekir.2021.11.039
193. PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying
immunogenetics: a review of literature. AbdelMassih AF, Menshawey R, Ismail JH,
Husseiny RJ, Husseiny YM, Yacoub S, Kamel A, Hozaien R, Yacoub E, Menshawey E,
Abdelmalek A, Abouelazaem A, Elhatw A, Aboelmaaty A, Shahib A, Mansour A, Kamal A,
Mohamed B, Atif B, Ghabreal B, Abdelmalak C, Ibrahim D, Elsaify E, Magdy F, Hanna FG,
Hafez H, Dahir H, Merhom K, Ahmed M, Bishara M, Tawfik M, Youssef M, El Sharnouby M,
Hamouda M, Ammar M, Ali N, Daniel N, El-Husseiny N, Abdelraouf N, Abdelhameed NK,
Ahmed R, Othman R, Mohamadein R, Allam R, Elgendy R, Shebl R, Elsherbiney S, Fouad S,
Emel S, Owais S, Hetta S, El-Saman S, Abdelalim S, Galal S, Asar Y, Osman Y, Khalaf Y, Aziz
Y, Khafagy Y, Gamal N, Castaldi B. J Genet Eng Biotechnol. 2021 May 31;19(1):82. doi:
10.1186/s43141-021-00179-2. PMID: 34057580 Review.
194. MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells.
Ragheb MA, Soliman MH, Elzayat EM, Mohamed MS, El-Ekiaby N, Abdelaziz AI, AbdelWahab AA. Anticancer Agents Med Chem. 2021;21(2):237-245. Doi:
10.2174/1871520620666200502004817. PMID: 32357822
195. Budd-Chiari syndrome diagnosed with pregnancy in a patient with inherited
thrombophilia. Elkhateb IT, Mousa A, Hashem A. BMJ Case Reports CP. 2021 Jan
1;14(1):e237761 https://pubmed.ncbi.nlm.nih.gov/33462015/
196. MicroRNA-372-3p Predicts Response of TACE Patients Treated with Doxorubicin
and Enhances Chemosensitivity in Hepatocellular Carcinoma. Soliman MH, Ragheb MA,
Elzayat EM, Mohamed MS, El-Ekiaby N, Abdelaziz AI, Abdel-Wahab AA. Anticancer Agents
Med Chem. 2021;21(2):246-253. Doi: 10.2174/1871520620666200516145830. PMID:
32416702
197. Accidentally discovered high INR in pregnancy unmasks an inherited factor VII
(FVII) deficiency that is paradoxically associated with thrombotic tendency. Elkhateb IT,
Mousa A, Eldeen RM, Soliman Y. BMJ Case Reports CP. 2021 Feb
1;14(2):e237781.https://pubmed.ncbi.nlm.nih.gov/33542014/
198. Simplified conservative surgery for placenta accreta spectrum (PAS): an
abnormally invasive placenta (AIP) case. Mousa A, Elkhateb IT. BMJ Case Rep. 2021 Jan
11;14(1): e237960. Doi: 10.1136/bcr-2020-237960. PMID: 33431457
199. Support for increased cardiovascular risk in non-segmental vitiligo among
Egyptians: A hospital-based, case-control study 2021 (DOI: 10.1111/pcmr.12941).
200. A miRNA’s insight into the regenerating heart: a concise descriptive analysis.
Afify AY. Heart Fail Rev. 2020 Nov;25(6):1047-1061. doi: 10.1007/s10741-019-09896-w.
PMID: 31838633 Review.
201. Video fluoroscopy of an obstructed mechanical replacement valve in pregnancy:
an iatrogenic. Mousa A, Elkhateb IT, Gaafar H. BMJ Case Reports. 2020 Sep
14;13(9):e237124.https://pubmed.ncbi.nlm.nih.gov/32928836/
202. An approach to diagnosis of paraproteinemia. In Paraproteinemia and related
disorder. Hegazy MT, Mahmoud AA, Attia H, and Ragab G.Quartuccio L, Goubran H. 2020,
Text Book: Paraproteinemia and Related Disorders, https://doi.org/10.1007/978-3-031-
10131-1
203. In vitro knock-out of miR-155 suppresses leukemic and HCV virus loads in
pediatric HCV-4-associated acute lymphoid leukemia: A promising target therapy Hassan
SS, El-Khazragy N, Elshimy AA, Aboelhussein MM, Saleh SA, Fadel S, Attia HA, Matbouly S,
Tamer N.. J Cell Biochem. 2020 Apr;121(4):2811-2817. doi: 10.1002/jcb.29512. Epub 2019
Nov 7.
204. Clinical and epidemiologic features of psoriasis patients in an Egyptian medical
center 2020 (DOI: https://doi.org/10.1016/j.jdin.2020.06.002)
205. Competing Endogenous RNAs in Hepatocellular Carcinoma-The Pinnacle of
Rivalry. Afify AY, Ibrahim SA, Aldamsisi MH, Zaghloul MS, El-Ekiaby N, Abdelaziz AI. Semin
Liver Dis. 2019 Nov;39(4):463-475. Doi: 10.1055/s-0039-1688442. Epub 2019 Jun 26.
PMID: 31242525 Review.
206. Advanced genetic manipulation in lupus: capturing butterflies in an abandoned
playground. Afify AY. Lupus. 2019 Oct;28(11):1378-1379. doi:
10.1177/0961203319871347. Epub 2019 Aug 29. PMID: 31466510
207. The long non-coding road to endogenous cardiac regeneration. Afify ARY. Heart
Fail Rev. 2019 Jul;24(4):587-600. doi: 10.1007/s10741-019-09782-5. PMID: 30900115
Review.
208. Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy:
Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell
Debate. Abushouk AI, Salem AMA, Saad A, Afifi AM, Afify AY, Afify H, Salem HSE, Ghanem
E, Abdel-Daim MM. Front Pharmacol. 2019 Jun 14; 10:635. Doi:
10.3389/fphar.2019.00635. eCollection 2019. PMID: 31258475 Free PMC article. Review.
209. Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through
repression of CD81 receptor in HCV cell models. Mekky RY, El-Ekiaby N, El Sobky SA,
Elemam NM, Youness RA, El-Sayed M, Hamza MT, Esmat G, Abdelaziz AI. Arch Virol. 2019
Jun;164(6):1587-1595. Doi: 10.1007/s00705-019-04232-x. Epub 2019 Apr 4. PMID:
30949812
210. Pharmacological Manipulation of Trk, p75NTR, and NGF Balance Restores
Memory Deficit in Global Ischemia/Reperfusion Model in Rats. Choucry AM, AlShorbagy MY, Attia AS, El-Abhar HS. J Mol Neurosci. 2019 May;68(1):78-90. doi:
10.1007/s12031-019-01284-1. Epub 2019 Mar 12. PMID: 30863991
211. Kasr Al-Ainy’s psoriasis unit protocol for the management of psoriasis, part I:
topical and systemic therapies 2019 (DOI: 10.4103/JEWD.JEWD_8_19).
212. Kasr AL-Ainy’s psoriasis unit protocol for the treatment of psoriasis, part II:
biological therapies 2019 (DOI: 10.4103/JEWD.JEWD_13_19).
213. Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA
Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma. Waly AA, El-Ekiaby N, Assal
RA, Abdelrahman MM, Hosny KA, El Tayebi HM, Esmat G, Breuhahn K, Abdelaziz AI. Front
Physiol. 2019 Jan 24; 9:1918. doi: 10.3389/fphys.2018.01918. eCollection 2018.PMID:
30733684
214. Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata
and quercetin in hepatocellular carcinoma. Shaalan YM, Handoussa H, Youness RA, Assal
RA, El-Khatib AH, Linscheid MW, El Tayebi HM, Abdelaziz AI. Nat Prod Res. 2018
Sep;32(18):2217-2220. Doi: 10.1080/14786419.2017.1366478. Epub 2017 Aug 18. PMID:
28817968
215. Correction to: Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity
through transcriptional and translational repression of Occludin. Elhelw DS, Riad SE,
Shawer H, El-Ekiaby N, Salah A, Zekri A, Amleh A, Esmat G, Abdelaziz AI. Arch Virol. 2018
May;163(5):1405. doi: 10.1007/s00705-018-3798-6. PMID: 29572597
216. Disruption of Claudin-1 Expression by miRNA-182 Alters the Susceptibility to
Viral Infectivity in HCV Cell Models. Riad SE, Elhelw DS, Shawer H, El-Ekiaby N, Salah A,
Zekri A, Esmat G, Amleh A, Abdelaziz AI. Front Genet. 2018 Mar 20; 9:93. Doi:
10.3389/fgene.2018.00093. eCollection 2018. PMID: 29616082
217. Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through
transcriptional and translational repression of Occludin. Elhelw DS, Riad SE, Shawer H,
El-Ekiaby N, Salah A, Zekri A, Amleh A, Esmat G, Abdelaziz AI. Arch Virol. 2017
Nov;162(11):3283-3291. Doi: 10.1007/s00705-017-3449-3. Epub 2017 Jun 22. PMID:
28642978
218. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood
mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus
patients. Sourour SK, Aboelenein HR, Elemam NM, Abdelhamid AK, Salah S, Abdelaziz AI.
Int J Rheum Dis. 2017 Sep;20(9):1237-1246. doi: 10.1111/1756-185X.13099. Epub 2017
May 19. PMID: 28523761
219. A randomized multicenter study: safety and efficacy of mini-pool intravenous
immunoglobulin versus standard immunoglobulin in children aged 1-18 years with
immune thrombocytopenia. Elalfy M, Reda M, Elghamry I, Elalfy O, Meabed M, El-Ekiaby
N, El-Hawy MA, Goubran H, El-Ekiaby M. Transfusion. 2017 Dec;57(12):3019-3025. doi:
10.1111/trf.14301. Epub 2017 Sep 6. PMID: 28880361 Clinical Trial.
220. MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R
in hepatocellular carcinoma patients. Rahmoon MA, Youness RA, Gomaa AI, Hamza MT,
Waked I, El Tayebi HM, Abdelaziz AI. Growth Factors. 2017 Jun;35(2-3):76-87. doi:
10.1080/08977194.2017.1354859. Epub 2017 Jul 27. PMID: 28747084
221. Reduction of CD19 autoimmunity marker on B cells of paediatric SLE patients
through repressing PU.1/TNF-α/BAFF axis pathway by miR-155. Aboelenein HR, Hamza
MT, Marzouk H, Youness RA, Rahmoon M, Salah S, Abdelaziz AI. Growth Factors. 2017
Jun;35(2-3):49-60. doi: 10.1080/08977194.2017.1345900. Epub 2017 Jul 7. PMID:
28683581
222. miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by
Inducing Expression of SREBP-1c and CAV1. Mahdy MM, El-Ekiaby NM, Hashish RM, Salah
RA, Hanafi RS, Azzazy HM, Abdelaziz AI. J Clin Transl Hepatol. 2016 Dec 28;4(4):293-299.
doi: 10.14218/JCTH.2016.00046. Epub 2016 Dec 26. PMID: 28097097
223. miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular
Carcinoma. Yacoub RA, Fawzy IO, Assal RA, Hosny KA, Zekri AN, Esmat G, El Tayebi HM,
Abdelaziz AI. J Clin Transl Hepatol. 2016 Dec 28;4(4):300-305. doi:
10.14218/JCTH.2016.00031. Epub 2016 Dec 27. PMID: 28097098
Conferences:
1. MENA Congress for Rare Diseases 2025, Abu Dhabi, UAE 1st MENA Summit for the
Limb Girdle Muscular Dystrophies “The Egyptian experience with limb girdle muscular
dystrophies” Dr. Rasha El-Sherif.
2. 403P: Impact of healthcare disparities, specialized care, and socioeconomic factors on
Duchenne muscular dystrophy patient outcomes: insights from an Egyptian referral
center; WMS 2025 Congress, in Vienna Austria 2025. El Sherif Rasha, Lowes Linda
3. 504VP: Limb-girdle muscular dystrophy R1 in Egyptian and regional patients: Clinical
spectrum, genetics, and registry insights; WMS 2025 Congress, in Vienna Austria 2025.
Rana Mowafy, Narhiro M, Nishino I, El Sherif Rasha
4. C3 Coalition to Cure Calpain 3’s LGMD2A/R1 Scientific Conference, September 2024,
Washington DC, Virginia, USA. “LGMDR1 patients from an Egyptian referral center” Dr.
Rasha El-Sherif
5. 494P: The Egyptian neuromuscular registry: a comprehensive platform for research
and clinical trial readiness for limb-girdle muscular dystrophy; WMS 2025 Congress, in
Vienna Austria 2025. Dina Hamed, El Sherif Rasha
6. WCN25-1937 SCIENCE IN MOTION: AMPLIFYING RESEARCH THROUGH THE ISN VIDEO
ABSTRACTS SERIES. Augusto Cesar Soares Dos Santos Junior, Ahmed Akl, Denisse
Arellano-Mendez, Dilushi Wijayaratne, Dyvia Bajpai, Mohammed Abdel Gawad, Hamze
Rage, Krithika Mohan, Manjusha Yadla, Milagros Flores Fonseca, Mythri Shankar, Priti
Meena, Sourabh Sharma, Suman Behera, SriKanth Bathini, Fernanda Arce-Amaré, 2025,
Kidney International Reports, Egypt.
7. WCN24-466 REACH OF ISN EDUCATION VISUAL ABSTRACTS VIA DIFFERENT SOCIAL
MEDIA PLATFORMS. Denisse Arellano-Mendez, Mythri Shankar, Suman Behera, Edgar
V. Lerma, Krithika Mohan, Ahmed AKL, Priti Meena, Divya Bajpai, Mohammed Abdel
Gawad, Fernanda Arce-Amaré, Augusto Soares dos Santos, 2024, Kidney International
Reports, Egypt.
8. WCN24-763 THE ISN VIDEO ABSTRACT SERIES IN PERSPECTIVE: GLOBAL EDUCATIONAL
REACH AND OUTCOMES. Augusto Cesar Soares dos Santos Junior, Ahmed AKL, Denisse
Arellano-Mendez, Dilushi Wijayarante, Divya Bajpai, Mohammed Abdel Gawad, Krithika
Mohan, Manjusha Yadla, Mythri Shankar, Fernanda Arce-Amaré, Priti Meena, Sourabh
Sharma, Suman Behera, 2024, Kidney International Reports, Egypt.
9. Syringocystadenoma Papilliferum Masquerading on the Auricle: A Rare Presentation
in an Elderly patient Yousra Azzazi, Hagar Elgezeri, Jawad Hamdan, Heba Abdelkader,
EADV symposium 2024
10. World Muscle Society 2024 Meeting, October 2024, Prague, Czech Republic. Dr. Rasha
El-Sherif
11. Cancer Associated Thrombosis, Hend Attia, 21st International Conference of the
Egyptian Society of Haematology and Research (ESHR), 2024, Egypt.
12. DOAC in POCT, Hend Attia, The EgyHealth international congress and exhibition, 2024,
Egypt.
13. YAP/TAZ and their downstream lncRNA SBDSP1 and miR-29a*: a trio regulating hepatic
lipid droplets via LDLR Hamad, Merna Hatem Mohamed, Ragheb, Manon, El Sobky,
Shereen Ahmed, Rose, Fabian, Breuhahn, Kai, El-Ekiaby, Nada, Fawzy, Injie Omar,
Abdelaziz, Ahmed Ihab, 2024, EMBL, Heidelberg, Germany
14. A long non-coding RNA (lncRNA) signature in blood defines activity of the oncogene
yes-associated protein (YAP) in tumor cells of cancer patients. Fabian Rose, Nada ElEkiaby, Fabiola Pedrini, Lilija Wehling, Merna Hatem Mohamed Hatem, Sofia ME Weiler,
Ahmed Ihab Abedelaziz, Kai Breuhahn, 2024, Non-coding RNA World 2024: Exploring
Mechanisms, Designing Medicines, Basel, Switzerland.
15. Exploring the interaction between YAP/TAZ and NOTCH2 and their downstream
lncRNA machinery in hepatic stellate cells, Nada El-Ekiaby, Amira Khaled Abdelhamid,
Manon Ragheb, Jennifer Schmitt, Kai Breuhahn, Ahmed Ihab Abdelaziz, 2024 Non-coding
RNA World 2024: Exploring Mechanisms, Designing Medicines, Basel, Switzerland.
16. WCN23-0264 E-LEARNING IN NEPHROLOGY-A WORLDWIDE SURVEY LOOKING AT
PRACTICE PATTERNS AND FUTURE NEEDS. S. BEK, S. Karam, E.K. Tannor, M. Gawad, M.
Yadla, Y.M. Nlandu, F. Arce-Amare, A.C. Soares dos Santos Junior, N. Moura, A. Canchi,
E. Lerma, U. Anand, J. Baharani, 2023, Kidney International Reports, Egypt.
17. WCN23-0304 New horizons for e-Learning in nephrology: The ISN Video Abstracts
Series initiative. A.C. Soares dos Santos Junior, S. Bek, F. Arce-Amaré, D. Wijayaratne, D.
Bajpai, M.A. Gawad, S. Behera, D.A. Mendez, A. Aki, R. Pecoits-Filho, 2023, Kidney
International Reports, Egypt.
18. Recovering the inhibitory impact of miR-105 on IGF1R via knocking down YAP/TAZMIR4435-2HG lncRNA axis in HCC Hamad, Merna Hatem Mohamed, Ragheb, Manon,
Rose, Fabian, El Sobky, Shereen Ahmed, Soliman, Hossam Eldeen, Negm, Mohamed,
Esmat, Gamal, El-Ekiaby, Nada, Fawzy, Injie Omar, Breuhahn, Kai, Abdelaziz Ahmed Ihab,
2023, 2nd International Liver Cancer Research Conference 2023, Heidelberg, Germany
Community Services
NGU- SOM, as an Egyptian university, aspires to lead in all aspects including community and environmental awareness, while valuing the importance of social responsibility as an integral part of medical education.
The school has a number of bodies that serve the community and develop the environment.
1- The Community Service and Environmental Development Affairs Committee implements and monitors plans.
2- New Giza University Community Hospital, in Sayeda Nafeesa serves patients free of charge in the fields of pediatrics, internal medicine, surgery and rare diseases.
3- Cooperation with the Crisis and Disaster Unit at the university
4-The NGU students’ clubs that share in medical conveys:
- Eight medical convoys were organized by the students’ clubs and with the participation of some members of the faculty.5-Awareness campaigns:
Campaigns a provided by the school and are carried out by students under the supervision of faculty members and have included awareness campaigns on hepatitis, diabetes and maintaining food safety
6- The Lancet Countdown Egypt Report has been launched from New Giza University and works to ensure that health is at the center of government response to climate change.
7-COP27-ASRT call for “Climate Change Adaptation and Nature Conservation”:
A multidisciplinary team was formed by the School of Medicine, the School of Information Technology, and the School of Engineering at New Giza University. The team submitted a concept note for a research proposal entitled: “Integrating Artificial Intelligence and Energy Simulation to Enhance Sustainability Standards for Educational Buildings: A Case Study of Occupant-Based Policies at New Giza University”. The team’s research was selected as one of the projects for the implementation plan of COP27
8-Misr ElKhair food distribution campaigns:
NGU students assist in that deliver the necessary materials to those in need. Including packing of Ramadan food boxes to be distributed to impoverished families.





Alumni
ALUMNI OFFICE
Coordinator of Alumni office: Mr. Sameh Ahmed
E-mail: Sameh.Ahmed@ngu.edu.eg
As an alumnus of our School of Medicine, we’re always looking for ways to support your ongoing learning and professional development. Whether you’re seeking to deepen your knowledge in a specific field or stay updated with the latest medical advancements so let’s stay in touch by updating your Alumni profile through this link:
-
-
- Alumni Profile: https://forms.office.com/r/AxEL3TgsvH
-
Also, we’ve found some excellent online platforms offering both free and paid certifications that can help you along the way.
Here are some great resources where you can explore and apply for medical-related courses:
-
-
- FutureLearn
FutureLearn partners with universities and healthcare organizations to offer medical courses, and many are free to access (you only pay if you want a certificate).
Check Out FutureLearn - Harvard Medical School Online Learning
Harvard Medical School offers a range of online learning programs, many of which are short-term and focused on current medical research, innovation, and clinical practice.
Visit Harvard Online Learning
- FutureLearn
-
Free Options:
-
-
- OpenWHO
OpenWHO offers free online courses developed by the World Health Organization (WHO), with many focused on global health emergencies, infectious diseases, and other public health topics.
Visit OpenWHO - OpenLearn
OpenLearn, by The Open University, offers free courses in science, health, and medical topics. It’s a great resource for a variety of learning needs.
Visit OpenLearn - Global Health Learning
Global Health Learning offers free courses focusing on global health issues, from infectious diseases to healthcare systems, ideal for those looking to explore health from an international perspective.
Explore Global Health Learning
- OpenWHO
-
These platforms offer high-quality, accredited courses that are trusted within the medical community. Whether you’re looking to specialize further, refresh your skills, or just learn something new, there’s something for everyone.
Feel free to explore these resources and take the next step in your continuous learning journey. If you have any questions or need further guidance, don’t hesitate to reach out.
Wishing you all the best in your professional growth!
For feedback please follow the link: https://forms.office.com/r/fAUJJr8P10
Vision
Continued support and open channels of communication with SOM graduates, allowing them to thrive in local and international workforces.
Mission
Establishing and maintaining contact with SOM graduates after graduation allows the University to continuously aid them in further development of their skills and tailoring their abilities to the match the needs of the medical labor market.
Graduation Ceremony Pictures
Class of 2022

Class of 2023

Class of 2024

Career Development Office
Coordinator of Career Development office: Dr. Mohamed Abdelgawad
E-mail: mohammed.gawad@ngu.edu.eg
- Fourth: Medical Liability Law

The Career Development Office (CDO) at the School of Medicine, Newgiza University, organized an online seminar on the Medical Liability Law, discussing its key provisions, implementation challenges, and impact on daily medical practice.
The session featured Prof. Osama Abdel Hay, President of the Egyptian Medical Syndicate, with contributions from Prof. Lamiaa Mohsen, Dean of the School of Medicine, and Prof. Tarek Kamel, Assessment Director at Newgiza University. The seminar was moderated by Dr. Mohammed Abdel Gawad, Coordinator of the Career Development Office.
The event targeted School of Medicine staff, students, and graduates and was held online via Zoom as part of the CDO’s ongoing efforts to support professional development and legal awareness in medical practice.
- Third Career Pathway Guidance Event

What Comes After Internship?
Medical Career Pathways in Egypt – A session you don’t want to miss!
Are you nearing the end of your internship and wondering where to go next? Whether you’re exploring clinical residencies, academia, public health or alternative paths, this session is tailored to help you navigate the future of your medical career in Egypt.
Second Career pathway Guidance Event


The Pathways to Medicine – Exploring Specialties for Your Future Career (Part II) event, held virtually via Zoom on February 27, 2025, at 9 PM, aimed to guide NGU medical students in selecting their specialties. Organized by the Career Development Office, the session featured doctors who shared their career journeys, challenges, and insights. Out of 215 registrants, 66 attended, actively engaging in discussions and expressing positive feedback. The event successfully achieved its goal of providing career guidance, and future sessions are planned to explore additional specialties to further support students in their career decisions.
First Career Pathway Guidance Event

The Career pathway Guidance Event, held on Wednesday, January 29th, at 9 PM, was a highly successful gathering aimed at helping NGU School of Medicine students and graduates explore career paths in internal medicine specialties. A total of 421 students and graduates registered, with approximately 224 attending the session. Experienced doctors from various internal medicine fields shared their journeys, insights, and advice, providing attendees with a clearer vision for their future.
Feedback from participants reflected great satisfaction, highlighting the value of the discussions and the opportunity to ask essential career-related questions. The event also emphasized upcoming sessions covering other medical specialties, as well as job opportunities for students and graduates. This marks the beginning of a series of insightful events designed to support NGU medical students in making informed career decisions.
Student Support
The student support team serves the undergraduate student community through group and individual meetings.
Aim
Our aim is to offer outstanding, clear and accessible advice on various matters. We recognise that medical students are subject to all sorts of stressors and having difficulty at some point during their academic journey is only to be expected. Our experienced staff can easily provide the right help and support for them, no matter what the problem may be.
Introduction to forms of support on offer
Regular support
For students who repeated the previous year or had to re-sit their summative exams
For students who get 50% or less in their midyear or cohort exams
Intensive support
For students repeating their academic year.
Revisiting part of the syllabus
For late admissions, transfer students and those who miss more than a few days of coursework with a valid and accepted excuse.
Psychological support
For students facing anxiety or depressive symptoms related to studying or examinations, family problems, peer problems or relational problems.
Responsible Faculty Roles & Responsibilities
- Student Academic Support Lead
Dr Omneya Kamel
- Student Academic Support Deputies
Dr Nancy Elghandour
Dr Mona Hafez
- Student Psychological Support Lead
Dr Maie Hilmy
- Student Psychological Support Deputies
Mental health team
Quality assurance and monitoring of teaching
QAU MISSION
The role of the Quality Assurance Unit (QAU) is: to support a culture of total quality management across the School of Medicine at NGU; to ensure that standards and guidelines within the teaching, learning and assessment processes for NGU’s undergraduate medical program are implemented; ensure that good practice is recognized and rewarded, and that any deficiencies that impact on the delivery of a high-quality program are rapidly identified and managed.
The systems and practices implemented by the unit aim to ensure the school works in partnership between staff and students to continually improve the educational program and learning environment. The unit targets the identification of good practices as well as deficiencies and obstacles. It works on: performance follow up; suggestions for development and enhancement; staff development; and the systematic review and development of processes, policies, strategies and priorities to support continuing improvement. The unit’s approach is aligned with the adopted quality assurance system of New Giza University and the National Authority for Quality Assurance and accreditation of higher education; aiming to fulfill the missions and vision of New Giza University and the School of Medicine.
OBJECTIVES
1- To promote awareness of quality principles and a quality culture throughout the school among staff and students.
2- To develop a collective self-critical and self-reflective attitude amongst all staff that enables them to produce and act on self-assessment and subsequent action plans.
3- To ensure that quality standards and guidelines are followed, to promote quality delivery, to detect and manage deficiencies, and to document and report quality assurance and improvement activities.
4- To support the development processes and the continuous quality improvement of education effectiveness.
5- To deliver the quality assurance functions that align with the University’s overarching QA vision and mission statements.
6- To ensure the university is well prepared to produce evidence of quality management and improvement to relevant stakeholders
Tuition Fees & Deadlines
Tuition Fees:
The School of Medicine tuition fees for the academic year (2025-2026): EGP 294,000 EGP +1,000 USD for Egyptian students. For more information, please click here.
Deadlines:
The deadline for the academic year 2025/2026 will be announced soon.
Apply Now
Fill out the online application form.
For more information about the application process and how to apply to the School of Medicine, please visit the Admissions section.
